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ABSTRACT
Aggregation of amyloid β (Aβ) protein has been linked to the development of Alzheimer’s
Disease (AD). The genesis of Aβ involves the cleavage Amyloid Precursor Protein (APP) by
β-secretase, producing the 99-residue C99 peptide, and the subsequent cleavage of C99 by
γ-secretase to produce Aβ. A detailed understanding of the γ-cleavage process is essential
to our undertsanding of the pathological mechanisms linking the aggregation of Aβ to the
development of AD. This work seeks to provide insight into critical aspects of the structure
and dynamics of C99, and the particular roles played by (1) C99 amino acid sequence and
(2) the lipid composition of the membrane environment. Many studies have focused on the
importance of the C99 sequence, including known studies of Familial AD (FAD) mutants as
well as engineered mutations. Specific mutations have been found to affect the processing
of C99, which has been linked to changes in the structure of C99 and the formation of C99
homodimers. Similarly, changes in the membrane environment, through variation in lipid
composition and the presence of cholesterol, have been found to affect C99 structure and
positioning within the membrane as well as C99 dimerization.
The results of this work extend our understanding of the APP-C99 system and its
interaction with the environment. Using a multiscale simulation approach, we find key
structural effects of engineered mutations that suggest possible mechanistic insight into the
γ-cleavage process. Using C99 congener peptides, we examine the effect of local membrane
environment on the dimerization of C99, focusing on the roles of both the transmembrane
v
(TM) region as well as the juxtamembrane (JM) domain. Further studies characterize the
role of a FAD mutation, and demonstrate the effect of the mutation on the dimerization of
C99 in agreement with experimental findings. Overall, this work leads to critical insight into
the role of sequence and membrane on the structure of C99 in a membrane environment,
and provides support for the conjecture that the structure of C99 monomer and homodimer
are critical to our understanding of the processing of C99, a critical step in the genesis of
Aβ peptide and the etiology of Alzheimer’s Disease.
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1Chapter 1
Alzheimer’s Disease and Aβ
Senile dementia is by no means a new condition. The progression of dementia with in-
creasing age has been noted since antiquity; a problem whose severity has only increased
along with average life expectancies. In 1906, Aloys Alzheimer was the first to characterize
a pathological marker associated with dementia [1, 2]. While examining the brain of a
woman who had died after years of dementia, he found neural plaques and fibrils; factors
which would become the hallmark of Alzheimer’s Disease (AD) - named for his discovery.
Continuing research into these markers picked up in the 1960s, when Terry and Kidd pub-
lished electron microscopy studies of AD cytopathology [3, 4]. These studies provided the
background for the 1984 work by Glenner and Wong at UCSD which uncovered the amyloid
core of these fibrils [5]. This discovery paved the road for the identification of the specific
protein which composes them: amyloid beta protein (Aβ).
In the century since Alzheimer’s discovery, researchers have continued to investigate
both Aβ itself and its genesis in the hopes of better characterizing the progression of
Alzheimer’s Disease. As average life expectancies across the globe continue to rise, cases of
AD and other forms of dementia rise as well. Current predictions suggest that the number
of people suffering from dementia in the US is expected to rise to 16 million by 2050 from
the current 4-5 million [1]. Although other proteins have also been linked to AD (prion pro-
tein, tau, etc.), the importance of Aβ in the development and pathology of the disease has
been demonstrated in numerous studies [6, 7], leading to the development of the “Amyloid
Cascade Hypothesis” proposed by Hardy and Selkoe [8]. Their hypothesis suggests that
accumulation of Aβ in the brain is the primary driving force for development of AD, and
that factors affecting the production of Aβ begin the “cascade” culminating in onset of the
disease.
21.1 Genesis of Aβ Protein
Aβ, the individual protein which aggregates to form the plaques and fibrils identified by
Alzheimer, is generated from a much longer peptide known as Amyloid Precursor Protein
(APP) [9]. APP is a Type 1 transmembrane (TM) peptide commonly found as a 770-residue
sequence [10], although other forms have been studied consisting of different chain lengths
[9, 11]. APP undergoes multiple sequential cleavage events to generate the final product
[12], and can be processed along two known pathways: the amyloidogenic (which generates
Aβ) and non-amyloidogenic pathways, both shown in Fig. 1.1.
In the non-amyloidogenic pathway, the initial cleavage event occurs extracellularly be-
tween residues K687 and L688 when APP is cleaved by the protein α-secretase. Since this
α-cleavage occurs within the Aβ strand, this pathway inhibits formation of Aβ protein and
instead generates the shorter, non-toxic p53 protein [13, 14].
In the amyloidogenic pathway - leading to the development of Aβ - the initial cleavage
occurs at the N-terminus of Aβ: residue 672 on the APP strand. This process is performed
by β-secretase and releases a large extracellular portion of APP (sAPP: soluble APP),
leaving behind a 99-residue long membrane-bound fragment of APP called C99 [15, 16,
17]. This fragment then undergoes cleavage inside the lipid membrane by a large protein
complex: γ-secretase [18, 19, 20], which generates Aβ and releases the Amyloid intracellular
domain (AICD).
In the early 2000’s, it was discovered that the γ-secretase cleavage pathway consists of
multiple cleavage events, beginning at the C-terminal end of the TM domain, and progress-
ing up the TM helix until a final cleavage event releases the Aβ peptide. The initial site
of cleavage, named the ǫ-site, was discovered to most commonly occur between residues
49 and 50 on the C99 peptide [21, 22, 23, 24]. Subsequently, another cleavage location,
the ζ-site was discovered further up the TM helix [25, 26, 27], and the sequential nature
of γ-cleavage was further demonstrated [28, 29]. Two predominant pathways are currently
known to exist (Fig. 1.2, resulting in the generation of a 40-residue peptide:Aβ1−40 and
3Figure 1.1: The two main processing pathways of APP. Left: an initial cleavage by
α-secretase generates extracellular sAPPα, and subsequent processing by γ-secretase
releases the non-amyloidogenic p53 peptide and AICD. Right: initial cleavage by
β-secretase releases extracellular sAPPβ leaving behind the C99 peptide, which gets
cleaved by γ-secretase to produce AICD and Aβ peptide.
a 42-residue peptide: Aβ1−42, respectively. In the first, initial ǫ-cleavage at residue 49 is
followed by ζ-cleavage at residue 46, and γ-cleavages at residues 43 and 40. In the second
pathway, ǫ-cleavage begins at residue 48, proceeds to ζ-cleavage at residue 45, followed by
γ-cleavage at residues 42 and possibly 38.
Figure 1.2: The main cleavage sites along the APP strand leading to Aβ1−40 (top)
and Aβ1−42 (bottom).
This variable secondary cleavage event is the crucial part of the process, since it can
result in a range of Aβ isoforms [30]. Aβ1−40 is the predominant form of Aβ, and is
also the least neurotoxic. The resulting distribution of Aβ1−42 to Aβ1−40 is closely linked
4to the development of AD. Changes in this ratio are correlated with the development of
the characteristic plaques and fibrils as well as with the onset of dementia [31, 32]. For
this reason, a better understanding of the cleavage of C99 by γ-secretase is crucial to
characterizing the early pathogenesis of AD.
1.2 Dependence on Membrane Environment
A crucial aspect of Aβ genesis is that γ-cleavage takes place inside the lipid membrane. γ-
secretase is part of a class of proteins known as iCLIPS, intramembrane cleaving proteases
[33, 34, 35]. The active site is buried within the membrane, and cleavage actually occurs
in the hydrophobic interior. This presents many challenges to experimental work, since
resolving the structure of either APP or γ-secretase while inserted into lipids is difficult,
and it makes it harder to probe the cleavage event by many standard means.
It also makes APP cleavage an interesting problem to study, since the exact mechanism
of cleavage for many iCLIPS remains unknown. γ-secretase is known to be an aspartyl
protease, yet it remains to be proven how the cleavage proceeds, and how water - a crucial
part of aspartyl cleavage - accesses the active site for cleavage to proceed.
In addition to the interesting questions raised by the location of the active site in γ-
secretase, the lipid environment has also been shown to play a crucial role in the structure
and positioning of APP in the membrane [36], and that changes to the environment can
affect the processing of APP [37]. Also, it has been shown that the presence of other factors
in lipids, like cholesterol, can affect processing of APP and are linked to the development
of AD [38, 39], although it remains unclear whether this happens solely because of changes
to the environment, whether cholesterol interacts directly with APP to affect processing,
or both. This means that gaining a better understanding of how APP relies on local
environment could be crucial to understanding the genesis of Aβ and factors affecting the
cleavage process.
51.3 Sequence
The genetic contribution to AD raises many interesting questions [2]. There are a number
of known single-site mutations associated with Alzheimer’s development or early onset of
the disease. While some of these mutations occur on Presenilin 1 (PS1), the subunit of γ-
secretase containing the active site, many have also been characterized on the APP strand
itself. The location of these mutations vary, suggesting differing effects which lead to either
increased chance or early onset of AD.
The earliest identified Familial Alzheimer’s Disease (FAD) mutations were a set of mu-
tations occurring at residue V46 (Aβ numbering). These “London” mutations included
V46I/L/F/G [40, 41, 42]. One important characteristic of these mutations, and others which
were later discovered in the three preceding residues, was that the mutations themselves
were located beyond the C-terminus of the Aβ-protein sequence, indicating that the muta-
tions were likely to affect processing of APP as opposed to affecting strictly the properties
of Aβ itself. Similarly, following identification of the London mutants, two residues located
immediately preceding the N-terminus of the Aβ sequence were identified as the location
of the “Swedish” variants of FAD mutations: K670N/M671L (APP-770 numbering)[43].
Again, the location of the mutations outside the Aβ strand, and at the site of β-cleavage,
suggested an influence on APP processing.
Subsequently a cluster of mutations was identified near the center of the Aβ strand
including the “Flemish” (A21G) and “Dutch” (E22Q) mutants [44, 45]. Due to their location,
these mutations could affect the processing of APP or the structure and aggregation of Aβ
post-cleavage by γ-secretase, or possibly some combination of both effects. The Flemish
mutant, in particular, presented with cerebral haemorrhage which has not been correlated
to other FAD mutants, suggesting a different mechanism for the pathology of the A21G
substitution [44].
In addition to characterized FAD mutations, many studies have also focused on “en-
gineered” mutations which aren’t known to be naturally occurring or genetically linked.
6These mutations are designed to test specific hypotheses about the structure, positioning,
and processing of APP by altering key residues in order to interfere with specific interactions
or properties of the peptide. Many studies with engineered mutants have been instrumen-
tal in developing a more detailed understanding of the role each residue plays, and their
importance in the genesis of Aβ protein [46, 47, 48, 49, 50].
1.4 APP Dimerization
Numerous studies have suggested that APP homodimerizes in vivo [51, 52, 53]. The exact
role of dimerization in the processing of APP by γ-secretase has yet to be established, with
some studies suggesting that dimerization might be a crucial step in the γ-pathway [54, 29]
while others suggest that dimerization inhibits processing [55].
One factor suggesting that dimerization might be important to the etiology of APP
processing is the existence of an extended GxxxG repeat motif in the sequence of the protein
[54]. These GxxxG motifs are known to enhance dimerization of TM α-helices, promoting
close right-handed coiled-coil packing [56]. This has especially been demonstrated in the
Glycophorin A (GpA) compound. In the wild type (WT) APP sequence there are three
sequential GxxxG repeats occurring from residue G25 to residue G37 [9].
The presence of these motifs suggests that dimerization of APP strands could play a
crucial role in the processing of APP to produce Aβ protein. The existence of a specific
interface enhanced by close-packing motifs might promote specific interactions between
APP and PS1 when being cleaved by γ-secretase. If the motifs on two interacting APP
strands were to interact during dimerization, it would promote a certain side of the APP
TM-helix being made available for processing opposite the dimer interface. One convenient
aspect of this theory is that the change in the cleavage site for Aβ1−40 and Aβ1−42 is two
amino acids - or half of a helical turn. If dimerization is a component of APP processing,
factors affecting the interface between dimers would alter which “face” of the TM-helix is
available for γ-cleavage, and potentially change the resultant length of Aβ produced.
7The role of APP dimerization remains contested. Certain studies suggest that homod-
imerization is crucial to APP processing [56, 51, 54], which others propose an inhibitory
effect [55]. Although the specific mechanism of APP dimerization in the γ-processing path-
way is not yet known, it remains an important characteristic of the APP system, and
providing a better understanding of dimer interactions may help elucidate the nature of the
specific role it plays in the genesis of Aβ.
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Methodology:
The sections in this chapter describe the general approach used to build the systems and
run any simulations. Any differences between individual systems are noted in the following
chapters.
2.1 Multiscale Approach
We employed a multiscale computational approach, combining molecular dynamics (MD)
and replica exchange MD (REMD) simulations [57], using models including (1) all-atom
representations of the protein in an implicit GBSW membrane [58], (2) coarse-grained
models of the protein, lipids, and solvent using the MARTINI force field [59, 60], and (3) all-
atom CHARMM36 force field models for the protein, membrane, and solvent environments
[61, 62, 63, 64]. Representations of the varying levels of resolution are shown in Fig. 2.1.
Chapters 4 and 5 employed all three levels of simulation, while chapters 3 and 6 only
employed levels (1) and (3).
In the first stage, REMD simulations of an all-atom model of the protein in an implicit
membrane allow us to explore the protein conformational ensemble. From those simula-
tions protein conformations representative of important substates composing the overall
ensemble were derived. These conformations were used to parameterize coarse-grained
MARTINI force field simulations of the proteins in a particle model of the phospholipid
bilayer. Coarse-grained simulations were used to assess the role of fluctuations in mem-
brane thickness, explicit interactions between protein and head groups, interactions due to
packing disorder in the lipid tail groups, and lipid composition of the membrane on the pro-
tein conformational ensemble. Subsequently, all-atom molecular dynamics simulations were
used to refine key substates identified in the CG simulations and characterize the detailed
9peptide-peptide, peptide-lipid, and peptide-solvent interactions. Results derived at varying
levels of resolution were tested for consistency. This approach leads to enhanced sampling of
the homodimer ensemble while simultaneously providing a detailed atomic-level picture of
the C9915−55 homodimer ensemble and its dependence on the bilayer environment [65, 66].
Figure 2.1: Depiction of the C9915−55 dimer system at varying levels of resolution
used in the multiscale modeling approach. Implicit membrane model (left), Martini
(CG) model (middle) and all-atom model (right).
2.2 APP Fragments: Starting Structures
For simulations of full-length C991−55, the initial structure was generated by combining
structural data from previous simulations of Aβ1−40 along with a helical segment through
residue 55 in the sequence. Structures for the C9915−55 systems were taken from NMR-
derived structures of C9915−55 determined experimentally in DPC micelles, without the
inclusion of the caps used in that study [67]. Structures for C9923−55 were generated to be
helical. All systems, regardless of length or sequence, were generated with the protein or
dimer strands located in the center of the bilayer environment, along the membrane normal.
Structures for all-atom simulations were selected from completed replica-exchange
molecular dynamics (REMD) [57] simulations of the desired systems. The number of
frames used varied for each system dependent on relevant structural features or ensembles
of interest.
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Mutations were introduced to the proteins using the VMD software package [68], and
mutant strands were minimized in CHARMM before beginning equilibration and production
runs.
2.3 REMD Simulations
All REMD simulations were performed in CHARMM [69], with an all-atom model of the
protein, and implicit representation of the solvent and membrane environments. The im-
plicit model used was the Generalized Born model with a switching function (GBSW) [58],
as implemented in CHARMM. This model uses a switching function at dielectric bound-
aries, and also models the head group regions of a membrane slab using a switching function
to provide a smooth change between the solvent region and the membrane interior. Interiors
were set to a dielectric value of 1, while the solvent region was set to a dielectric value of
80.
Proteins were modeled using the CHARMM PARAM22 force field with dihedral cross-
term corrections (CMAP) [70], and with corrections specific for the GBSW model. Updated
atomic radii for the GBSW model were also used [71]. The smoothing length used at
dielectric boundaries was 0.6 Å, with 24 radial integration points, and no cutoff. The
surface tension coefficient was set to 0.04 kcal/(mol · Å2). The membrane was defined as
a continuous slab in the xy plane, with the membrane normal lying along the z-axis. The
timestep used for MD steps was 2 fs, and exchanges between neighboring replicas were
attempted every 0.5 ps. Replicas were maintained using the MMTSB tool set [72]
2.4 All-Atom Simulations
Structures were inserted in pre-equilibrated POPC bilayers using the CHARMM-GUI [73,
74, 75]. All-atom simulations were carried out in GROMACS [76, 77]. After the initial
structures were embedded in the bilayer, all structures underwent steepest descent mini-
mization, followed by 100 ps of NVT and 2 ns of NPT equilibration. Each structure was
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then simulated for 100 ns, with the initial 50 ns excluded from analysis.
Explicit all-atom simulations were performed using the CHARMM36 force field and
TIP3P water atoms with a time step of 2 fs [78, 79]. PME was used to calculate long-
range electrostatics, and short range electrostatics had a cut-off at 1.0 nm. A Nosé-Hoover
thermostat was used along with a Parrinello-Rahman barostat to control the temperature
and pressure [80]. The POPC bilayer consisted of 128 lipid molecules (64 each on the top
and bottom layers), and the system was completed with TIP3P water molecules extending
20 Å on each side of the bilayer, and any necessary counter-ions to provide a neutral system.
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Chapter 3
Engineered mutations to residue K28 affect the structure and
positioning of APP-C99 peptide in lipid bilayer
3.1 Introduction
Alzheimer’s Disease (AD) is currently the leading cause of dementia worldwide, and is
estimated to be responsible for more than 65% of late-life dementia cases [1]. The amyloid
β (Aβ) hypothesis suggests that the Aβ protein plays a critical role as a pathogenic agent in
AD [8, 81]. The characteristic plaques and tangles associated with AD were first discovered
by Aloys Alzheimer in 1906 [1], and in 1963 the individual protein itself, Aβ, was first
identified [3]. Despite decades of research since that time, however, many questions remain
surrounding the specific causes of not only the neurotoxicity of Aβ, but also the precise
mechanisms controlling its genesis. The Aβ protein itself is a natural byproduct of regular
cell functions, resulting from the cleavage of amyloid precursor protein (APP) [12, 14].
In its most common form, it exists as a 40-residue long peptide (Aβ40) predominant in
cerebrospinal fluid and plasma [81]. Various isoforms of Aβ can result, however, and amyloid
plaques in patients with AD are enriched with a slightly longer 42-residue peptide (Aβ42).
Aβ40 and Aβ42 have been shown to exhibit different aggregation patterns [32], oligomer
structures [31], and toxicity levels [82].
APP is a type I transmembrane protein which exists in isoforms ranging from 365
amino acids to the most common isoform of 770 amino acids [14, 7]. It can undergo two
separate cleavage pathways; in the non-amyloidogenic pathway, APP is first cleaved by α-
secretase [83, 13] then by γ-secretase [20], yielding the N-terminally truncated p53 peptide.
In the alternate amyloidogenic pathway, β-secretase [17] cleaves at the N-terminus of Aβ
yielding the membrane-bound APP-C99 fragment which may then be cleaved by γ-secretase
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to yield Aβ. Cleavage of APP-C99 by γ-secretase is known to occur by sequential proteolytic
events beginning at the ǫ-site (commonly Leu49-Met50), and proceeding to the final - variable
- γ-site, which determines the isoform of Aβ generated [27, 25, 26].
There are many single-site mutations, both familial [84, 85, 86] and engineered [48, 87],
which are known to affect the initial location or progression of these sequential cleavage
events, and therefore alter the ratio of isoform distributions of Aβ. Many of these mutations,
especially the familial mutants, are located in the region of the protein where the sequential
cleavage events occur: residues Thr43-Val46. However, some mutations have also been
studied which are located at the opposite end of the membrane, far removed from the
actual location of cleavage, and yet have marked effects on the resulting isoforms of Aβ.
One focus of study has been on the role of Lys28, where engineered mutations have been
shown to affect the length of the isoforms produced after γ-cleavage [46, 47, 48, 49, 50].
Although the exact mechanism of this change in the cleavage location is not yet known,
studying the effects of mutations at this critical location in the APP sequence will help gain
a deeper understanding of the genesis of Aβ.
Figure 3.1: Four different C991−55 systems highlighting location of residue 28 for
all sequences studied: Wild-type (blue), K28A (green), K28E (red), K28Q (orange).
This study examines the mutant systems analyzed by Kukar and coworkers (K28A,
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K28Q) [48], as well as the often-investigated K28E mutation [47, 49, 50], in the hopes of
providing an atomic-level view of changes caused by these specific single-site mutations
(Fig. 3.1). Mutations at Lys28 have resulted in a variety of effects on the processing of
APP. K28S mutation has been shown to cause almost a 90% decrease in Aβ production
[46], while the K28E mutation causes a less drastic reduction in Aβ40 and Aβ42 amounts
accompanied by an increase in the shorter Aβ37 and Aβ38 peptides [47, 49, 50]. The K28A
and K28Q mutants have also been shown to increase production of shorter Aβ isoforms
at the expense of Aβ40, especially in the case of K28A mutation, which nearly abolishes
production of any Aβ isoforms longer than 34 residues [48, 50].
In order to reduce the system size and focus study on the transmembrane domain (TMD)
of the protein, the first 55 residues of the full APP-C99 strand were used. This fragment
(which we refer to as C991−55) comprises the entire Aβ strand as well as the following 15
residues of APP-C99. It extends through the TMD, and ends in three terminal Lys residues,
providing a stable anchor to ensure that the protein remains embedded in the membrane
as full-length APP-C99 would. Using a multiscale approach of implicit replica-exchange
and all-atom simulations, the conformational changes and membrane interactions of these
systems were analyzed and compared to experimental results to provide a more detailed
understanding of the genesis of the Aβ protein in C991−55. Structural changes induced
by sequence variation are characterized in terms of TM helix tilt and depth of insertions,
as well as the stability of the TM helix, which has been studied for its effect on cleavage
efficiency [36, 29]. These structural changes were found to be correlated with the impact
on processing by γ-secretase. These observations provide a foundation for the formation of
structure-activity relations (SAR) describing the impact of C99 mutation to the production
of Aβ.
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3.2 Methods
3.2.1 Multiscale Simulation
In order to adequately sample the entire structural ensemble of each system while also
being able to investigate detailed interactions between the proteins and the environment,
a “multiscale” approach was used consisting of two different levels of simulation. First,
structures were simulated using the replica-exchange molecular dynamics (REMD) [57]
method in order to increase conformational sampling. In REMD simulations, noninteracting
replicas are each started at different temperatures, and regular MD steps are carried out
at each temperature. At exchange steps, neighboring replicas have a chance to exchange
temperatures according to the Metropolis criterion. This allows the replicas to diffuse across
temperatures, and escape any local minima while sampling the conformational space.
Once REMD simulation was completed, the resulting structural ensembles for each
peptide were investigated and clustered into relevant local minima in order to draw starting
structures for explicit all-atom simulation. The explicit simulation allowed for more specific
investigation of interactions between the proteins and the surrounding lipids and water
molecules, without the approximations of the implicit environment. Once the all-atom
simulations were completed, the two predominant structures for each peptide sequence
were selected and used for analysis.
3.2.2 Initial Structures and Mutations
The initial structure used for the wild-type strand was built by generating a helical structure
for the 55-residue sequence:
DAEFR5HDSGY10EVHHQ15KLVFF20AEDVG25SNKGA30
IIGLM35VGGVV40IATVI45VITLV50MLKKK55
The positions for the first 12 residues of the sequence were then replaced with the positions
from a previous simulation of the Aβ40 protein, while remaining residues were kept in a
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helical configuration. The new structure was minimized and oriented with respect to the
membrane, so that the peptide was aligned along the membrane normal. This configuration
was used as the starting structure. In addition to the wild-type peptide, three single-site
mutants were investigated: K28A, K28E, and K28Q, where the lysine at residue 28 (shown
in bold) was replaced by alanine, glutamic acid, and glutamine, respectively. These four
systems cover all four types of amino acids at residue 28. For the mutant strands, the point
mutations were constructed in VMD [68], and the resulting peptides were again minimized
in CHARMM before equilibration and production.
3.2.3 Simulation Parameters and Force Fields
For the REMD simulations, 24 replicas were used to span a temperature range from 300
to 650 K. The timestep used for MD steps was 2 fs, and exchanges between neighboring
replicas were attempted every 0.5 ps. The total simulation time was 168 ns (10.5 ns for each
replica), and the initial 1 ns of simulation time for each replica were thrown out to remove
any dependence on the initial structure. Replicas were maintained using the MMTSB tool
set [72]
All REMD simulations were performed in CHARMM, with an all-atom model of the
protein, and implicit representation of the solvent and membrane environments. The im-
plicit model used was the Generalized Born model with a switching function (GBSW) [58],
as implemented in CHARMM [69]. This model uses a switching function at dielectric
boundaries, and also models the head group regions of a membrane slab using a switching
function to provide a smooth change between the solvent region and the membrane interior.
For implicit simulations, the proteins were modeled using the CHARMM PARAM22
force field with dihedral cross-term corrections (CMAP) [70], and with corrections specific
for the GBSW model. Updated atomic radii for the GBSW model were also used. The
smoothing length used at dielectric boundaries was 0.6 Å, with 24 radial integration points,
and no cutoff. The surface tension coefficient was set to 0.04 kcal/(mol · Å2). The membrane
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was set to a total width of 40 Å, with 5 Å at each end defined as the ”head group” switching
region, leaving a total of 30 Å as the membrane interior, with a dielectric value of 1. The
switching function for the head group region then varied from the interior value to the
solvent region, with a dielectric value of 80. The membrane was defined as a continuous
slab in the xy plane, with the membrane normal lying along the z-axis.
From the completed REMD simulations, representative frames were selected as “seed
structures” for all-atom simulations performed in GROMACS [76, 77]. Structures were
inserted in pre-equilibrated POPC bilayers using the CHARMM-GUI [73, 74, 75]. All
structures underwent steepest descent minimization, followed by 100 ps of NVT and 2 ns
of NPT equilibration. Each structure was then simulated for 100 ns, with the initial 50 ns
excluded from analysis.
Explicit simulations were performed using the CHARMM36 protein and lipid force
field, and the TIP3P water force field, with a time step of 2 fs [78, 79]. PME was used to
calculate long-range electrostatics, and short range electrostatics had a cut-off at 1.0 nm.
A Nosé-Hoover thermostat was used along with a Parrinello-Rahman barostat to control
the temperature and pressure [80]. The seed structures from the REMD calculations were
embedded into a POPC bilayer consisting of 128 lipid molecules (64 each on the top and
bottom layers), and the system was completed with TIP3P water molecules extending 20 Å
on each side of the bilayer, and any necessary counter-ions to provide a neutral system.
3.3 Results
3.3.1 Mutation of K28 impacts salt-bridge formation
The first step in the multiscale modeling approach was to perform REMD simulations of
the wild-type and mutant C991−55 systems in an implicit GBSW membrane environment
[58] to sample the configurational space for all sequences. The mutations at residue 28 had
a strong impact on the structures sampled in each system, as well as on select intrapeptide
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Figure 3.2: Conformational distributions of C991−55 in implicit membrane REMD
simulations of all four C991−55 sequences, projected onto key order parameters (1)
the salt-bridge distance between residues E22/D23 and residue 28 in each system
and (2) the angle between the JM and TM regions of C991−55.
Figure 3.3: Representative structures of C991−55 in implicit membrane REMD
simulations of all four C991−55 sequences, showing variety of structural ensembles.
From left to right: WT (blue), K28A (green), K28E (red), K28Q (orange).
interactions. In order to characterize the ensembles for each system, the REMD results were
analyzed along two main order parameters: the distance between residue 28 and residues
E22/D23, and the angle between the juxtamembrane (JM) and TM regions. Fig. 3.2 shows
the projection of the REMD simulations onto those order parameters.The differences in
certain representative structures for each system can be seen in Fig. 3.3. The mutation
has a clear effect on the variety of structures sampled, especially in the JM region of each
peptide system.
In the wild-type sequence, K28 can form a salt bridge with the acidic E22/D23 residues
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stabilizing a turn at the interfacial region of the protein. This salt-bridge interaction has
been examined in studies of Aβ aggregation and found to promote a turn in the protein
allowing for close β-interactions and packing between peptides to form fibrils [88, 89]. In
the APP strand, however, this interaction occurs immediately N-terminal to the bilayer.
The JM region of APP contains the sequence L17VFFA21, which is known as the central
hydrophobic cluster (CHC) of Aβ. In the WT projection in Fig. 3.2, the cluster in the
lower left of the plot is a region with close 22/23-28 interactions as well as a small angle
between the JM/TM regions, suggesting that the salt-bridge facilitates reinsertion of the
CHC into the bilayer. Changes to residue 28 appear to destabilize this interaction, and
affect the positioning of the JM and TM regions relative to the membrane, as well as the
structure of these regions. As seen in the mutant peptide projections in Fig. 3.2, the lower
left cluster present in the WT peptide is absent in the mutant systems, although the K28E
and K28Q systems both have a small cluster with a distance of around 6 Å, and a much
larger JM/TM angle near 120-140 degrees.
3.3.2 Helix formation inhibits reinsertion of JM domain in POPC bilayer
Frames were selected from the predominant clusters for each system, and used to seed all-
atom simulations in a POPC bilayer. When the simulations were analyzed, each C991−55
structural ensemble was found to be characterized by two principal structural forms, as
shown in Fig. 3.4. In the wild-type strand, one cluster was characterized by structures
having a stable JM-helix, which remained separate from the bilayer, while the other cluster
featured structures with a β-strand formed from interactions between residues Q15 and
F20, as was found in a recent structural study of C991−55 using FTIR spectroscopy [91]. In
this second form, the CHC can be shown to reinsert into the POPC bilayer (Fig. 3.5).
In theWT peptide, the JM helix is composed entirely of the CHC residues (K16LVFFA21),
in agreement with previous studies predicting the existence of a nascent JM helix [90, 67, 92].
This helix was also observed in the K28A and K28Q systems, while the K28E system formed
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Figure 3.4: Distributions of C991−55 peptides in POPC bilayer derived from all-
atom simulations, showing average location of each residue relative to the head-group
region of the bilayer (colored bars), helix population (black line), and β-structure
(dashed line). Negative values indicate insertion into the membrane. Experimental
power saturation EPR measurements (gray bars) [90]. The orange dashed line over-
laid on the WT data indicates helicity values calculated from Cα chemical shift NMR
data [67]. Shaded gray area marks CHC.
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Figure 3.5: Characteristic structures of two dominant conformations of the WT
peptide derived from all-atom simulations in POPC bilayer: (a) Helical JM region
localized at the bilayer interface or (b) CHC region inserted in the lipid bilayer. Grey
beads show the location of residues K16LVFFA21, and lipid domain is marked as a
translucent surface.
a helix N-terminal to this location on the strand at residues S8GYE11. The reinsertion of
the CHC into the bilayer was observed in all systems except the K28Q peptide, and only
occurs in the absence of any JM helical content for the mutant systems as well as the WT
peptide. This region of reinsertion has been previously reported for C991−55 in surfactant
micelles [67].
3.3.3 Reorganization of JM domain in mutant forms of C991−55
To investigate the effect of mutation on the salt-bridge interaction, the distances between
residue E22-28 and D23-28 were calculated independently from all-atom simulations of
C991−55 in POPC bilayer as shown in Fig. 3.4. The results of this calculation are shown in
Fig. 3.6. Distances between residues were calculated between the terminal portions of each
amino acid (e.g. the carboxyl group on acidic residues, or the terminal methyl group on
the alanine residue). Similarities can be seen for structures containing a helical CHC region
in the WT, K28A, and K28Q systems, where there is an intermediate distance (∼5-10 Å)
between residues 23 and 28, and a larger distance (∼15-20 Å) between residues 22 and
22
0.2
0.4
0.6
Po
pu
la
tio
n
WT
Po
pu
la
tio
n E22−K28
22−28 Dist
23−28 Dist
24−28 Dist
0.2
0.4
0.6
Po
pu
la
tio
n
K28A
Po
pu
la
tio
n
0.2
0.4
0.6
0.8
Po
pu
la
tio
n
K28E
Po
pu
la
tio
n
0.2
0.4
0.6
5 10 15 20 25
Po
pu
la
tio
n
Salt Bridge Dist. (Å)
K28Q
Po
pu
la
tio
n
5 10 15 20 25
Salt Bridge Dist. (Å)
Figure 3.6: Residue pair distributions for C991−55 in POPC bilayer derived from all-
atom simulations. Shown are normalized distributions for the 22-28 distance (dashed
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Figure 3.7: Characteristic structures derived from all-atom simulations in POPC
bilayer showing reinsertion of the CHC region of the (left) K28A mutant peptide
and (right) K28E mutant peptide. Grey beads show the location of CHC residues
K16LVFFA21, and lipid domain is marked by the translucent surface.
28. In the K28E mutant, where interactions between residues 22/23 and residue 28 involve
acidic residues in close proximity, neither of the two main structures show close contact
interactions observed in the WT, K28A, and K28Q systems. Destabilization of this critical
contact may account for the loss of helicity in the CHC region of the K28E peptide.
While structures with a helical CHC region have similar interactions between residues
23 and 28, interactions leading to reinsertion of the CHC region into the bilayer are more
varied between systems. In the WT peptide, Fig. 3.6 shows a close salt-bridge formed
between residues E22 and K28. Both the K28A and K28E systems, however, show little
interaction between residue 28 and either of the acidic residues. Both systems, however,
accommodate the change of those interactions in different ways. Whereas the WT structure
with reinserted JM region adopts an “S”-like structure allowing reinsertion of the JM region,
the K28A structure adopts a spiral “O”-like shape, establishing a greater distance between
residues 22/23 and 28 (see Fig. 3.7, left). In the K28E structure (Fig. 3.7, right) the same
“S”-bend is seen as in the WT, however, the TM-helix is extended toward the N-terminus
(Fig. 3.4), which accounts for the observed changes in intrapeptide contacts.
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Figure 3.8: Distributions of kink and TM-helix tilt angles derived from all-atom
simulations of C991−55 in POPC bilayer for each system. Coloring indicates RMS
deviation from an ideal helix in nm over the TM domain.
3.3.4 Sequence-structure relations for TM domain of C991−55 in POPC
bilayer
The point mutations studied also impact the position of the TM domain of C991−55. Fig. 3.8
shows the correlation of helix tilt and kink angles for the dominant clusters for each pep-
tide system. Kink angles were calculated at residues G37/G38, with a value of 0 degrees
indicating a straight TM helix. The TM angle was calculated for the N-terminal portion
of the TM helix (up to residues G37/G38), and is given as a deviation from the membrane
normal. Predominant structures in the WT system had smaller values for both the kink and
tilt angles. Especially in the structure with a JM helix, the tilt relative to the membrane
normal is below 30 degrees, with less than 15 degrees of kink in the helix. The reinserted
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structure shows slightly larger kink angles (up to 20 degrees), but both structures deviate
only slightly from an ideal helix.
The K28E mutant system shows similar positioning to the WT system, with both struc-
tures characterized by tilt values below 30 degrees. However, the reinserted structure shows
no tilt values lower than 10 degrees, in contrast to the WT. The reinserted K28E struc-
ture is characterized by slightly larger kink values than the WT, which might result from
the extended TM helix. In contrast to the WT and K28E peptides, both the K28A and
K28Q mutant strands have structures that are less tilted featuring stable JM helices, and
alternative structures with heavily tilted TM portions.
3.4 Discussion
3.4.1 WT C991−55 adopts two characteristic conformational states
The role of the JM region of C99 in the processing of APP by γ-secretase is currently unclear.
Studies have found that mutations in this region can inhibit production of Aβ [93] as well as
alter the resultant isoform distribution following γ-cleavage [46, 47, 48, 49, 50]. Structural
studies of this region have suggested that the JM region may contain a moderately stable
helical domain [92] that could play an important role in C99 homodimerization. The most-
often reported structure found in that region was a nascent helix [67, 92, 90], but a recent
study done using FTIR spectroscopy found evidence of β-structure in this region [91].
We find that the WT APP strand adopts two predominant conformational states, one
featuring a helical JM domain, and the other stabilized by β interactions between residues
Q15 and F20 (Fig. 3.4). These results agree with previous structural studies of APP sug-
gesting that the WT JM structure might be inherently more flexible than the TM domain.
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3.4.2 CHC helicity and bilayer insertion are distinct substates
Some studies have suggested that the CHC region of C99 forms a helix that is reinserted
into the membrane [67, 92, 90]. In contrast, this study found that helicity in the CHC region
is distinctly separate from structures where it is reinserted into the membrane bilayer. This
was demonstrated across all four of the peptide systems investigated (Fig. 3.4). As seen
in the WT, K28A, and K28Q systems, the formation of a JM-helix was correlated with
extended JM structures localized near the bilayer interface. In contrast, when the CHC
region reinserted into the membrane, no helical content was observed in the JM region.
Reinsertion of the CHC region was also found to be correlated with an increased peptide
kink at the G37/G38 residues (Fig. 3.8). This suggests that reinsertion of the LVFFA
residues of the CHC imposes a steric effect on the peptide requiring an increased kink to
allow the turn at the interfacial region to form.
The two observed characteristic structures of the CHC region were associated with
distinct intrapeptide interactions, especially in the WT system. In the structure containing
a JM helix, the salt bridge formed between residues E22/D23 and K28 was much weaker and
more diffuse, and featured stronger interactions involving D23 than E22. In the reinserted
structure, the salt bridge was very well formed, and the interaction shifted to residue E22,
which remained at distances of < 5Å from residue K28. This close salt bridge formation
was not seen in any of the mutant systems, being destabilized by replacing the positive
charge at residue 28, and might account for the loss of β-structure in the mutant peptides.
3.4.3 Mutations at residue K28 strongly affect peptide structural ensem-
ble
All mutations studied had pronounced and distinct effects on the structural ensemble of the
C991−55 peptide. Mutation of cationic K28 to polar (K28Q), non-polar (K28A), and acidic
(K28E) residues destabilized the strong salt bridge capable of forming in the WT. While
this interaction stabilizes the β-interaction allowing for reinsertion in the WT peptide, the
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K28A and K28E systems both adjusted to allow for reinsertion in differing ways.
In the K28A system, the peptide adopted a strongly kinked and tilted structure, which
positioned the N-terminal region of the TM domain at a sharp angle relative to the mem-
brane normal (Fig. 3.8). This structure satisfied the steric requirements to allow reinsertion
of the CHC without formation of the E22/K28 salt bridge. The K28E system, in contrast,
avoided unfavorable acid/acid interactions introduced by mutation by extending the TM
helix through residue V24. This structural feature can be seen both in Fig. 3.4 (K28E,
right), as well as the close interaction between residues V24/E28 in Fig. 3.6, which arises
from the two residues being one helical turn apart.
The K28Q system also adopted a more heavily kinked and tilted structure, similar to the
K28A system (Fig. 3.8), but due to the increased stability of the JM helix in this peptide,
little or no reinsertion of the CHC region was observed.
3.4.4 Possible effects of secondary structure and peptide position on pro-
cessing by γ-secretase
Each of the mutations studied have been found to decrease production of Aβ1−40 in favor
of shorter Aβ fragments [47, 48, 49, 50]. It was suggested when the luminal region of C99
was first investigated that the positive charge located at residue K28 might be necessary
for normal processing by γ-secretase to occur [46]. Indeed, studies of the K28R mutant
have shown cleavage patterns for the mutant peptide that are almost identical to WT C99
[46, 49, 50].
The positive charge of K28 appears to stabilize the salt bridge formation favoring β-
structure, which, in this study, was only observed in the WT sequence, and was correlated
with reinsertion of the CHC region. As suggested by Kukar et al., for normal γ-cleavage to
occur there might be a steric hindrance imposed by the JM region inhibiting the C99 strand
from being more deeply inserted into the membrane to allow further sequential processing
by γ-secretase. The interfacial turn and reinsertion of the CHC could provide that steric
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barrier. One way this could be investigated in future studies would be to examine double
mutants, where the K28E mutation would be combined with mutations at residues E22/D23
to recreate a salt bridge turn and potentially rescue normal γ-processing.
Another possible mechanism for mutations to affect the processing was presented by
Ousson et al. suggesting that a change in membrane positioning or tilt could affect the
locations of individual residues within the bilayer, allowing for further processing to generate
shorter Aβ fragments [49]. This theory is also supported by our results, with the K28E
strand (known to favor Aβ37 production) showing a slight increase in tilt, and the K28A/Q
systems (both favoring shorter Aβ33/34 fragments) showing a dramatic increase in the
N-terminal peptide tilt. Support for these two possible mechanisms helps provide more
foundation on the SAR of the C991−55 peptide.
Other proposed theories involve specific interactions of the APP sequence with PS1
or other subunits of γ-secretase, which is beyond the scope of this work. These proposed
mechanisms for JM mutations within the Aβ strand to affect and alter processing by γ-
secretase must be critically evaluated in future studies.
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Chapter 4
Transmembrane domain homodimer of Amyloid Precursor
Protein adopts multiple conformational substates in lipid
bilayers 1
4.1 Introduction
Amyloid precursor protein (APP), a membrane-bound protein, is processed to release the
amyloid-β (Aβ) peptide whose aggregation is linked to Alzheimer’s Disease (AD). APP is
known to undergo sequential cleavage, beginning with processing by β-secretase to release
the 99 amino acid C-terminal fragment, APP-C99 (C99) [94], which is then processed by
the γ-secretase complex starting at the C-terminal transmembrane (TM) helical region, and
ending with the release of Aβ protein [28, 95, 96]. Many factors affect γ-secretase cleavage,
including sequence [97, 54], TM helix stability [98, 36, 29], dimerization of C99 peptide
[51, 53, 55, 99], as well as membrane composition [36].
Several studies of monomeric C99 have provided details of the peptide structure, particu-
larly the TM helix. Early NMR structural studies of C99 in an LMPG micelle environment
noted the existence of a flexible GG-kink in the TM helix near G37/G38 [90]. We had
predicted the presence of such a kink using simulations of C991−55 in an implicit mem-
brane environment [100], noting a flexible “hinge” at G37/G38 flanked by an N-terminal
helix (Domain B) and C-terminal TM helix (Domain C), with Domain B showing larger
fluctuations. These findings were in agreement with previous NMR studies [67]. We also
discovered a third helical domain in the N-terminal juxtamembrane region (Domain A). A
recent study involving H/D exchange experiments on the C99 peptide complemented with
molecular dynamics simulations of C9928−55 in a POPC bilayer also support this view of
1All coarse-grained and all-atom simulations and analysis in this chapter were performed by Dr.
Laura Dominguez.
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Figure 4.1: Different C9915−55 dimer interfaces. Left: a C9915−55 GxxxG motif at
the interface and a right-handed crossing angle between the helices; Center: GxxxA
motif at the interface with a right-handed crossing angle between the helices; Right:
GxxxA interface with a left-handed crossing angle between the helices. Key Gly
residues (G29, G33, G37 and G38) are shown in green and Ala 42 is shown in red.
the monomer structure consisting of three principal helical domains [29]. Thus, there is
considerable agreement between theory and simulations regarding the structural ensemble
of C99 monomer in membranes.
The earliest proposed structure for the C99 homodimer was inspired by sequence analy-
sis, noting GxxxG repeats in the TM domain and homology with glycophorin A (GpA), in
which GxxxG repeats facilitate interpeptide interactions stabilizing a right-handed coiled-
coil homodimer [54]. Subsequent work supported this model, including NMR studies of
C99 in a micelle environment [67]. In addition, the first simulations of the homodimer of
C9923−55 in a membrane environment [100] suggested a λ-like right-handed helical dimer
structure stabilized by the GxxxG motifs, consistent with solid state NMR studies [98], as
shown in Fig. 4.1 (left).
Subsequently, coarse-grained MD simulations refined by all-atom modeling provided
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additional support for this model, while also noting the potential importance of interpeptide
interactions mediated by the G38xxxA42 motif [101]. Further support for the importance of
this secondary structural motif was provided in a subsequent study involving H/D exchange
experiments on the C99 peptide complemented with molecular dynamics simulations of
C9928−55 in a POPC bilayer [29], as well as a model predicted by Monte Carlo searches of
TM helix interactions [53].
Recently, the first experimentally-derived solution-phase structure of a homodimer of
the TM domain of C99 in a detergent micelle was proposed, suggesting a dominant X-
shaped left-handed coiled-coil structure stabilized by the GxxxA motif [92] (Fig. 4.1, right).
Given past evidence based on mutation studies, NMR studies, and simulation suggesting a
right-handed coiled-coil structure, this finding is a surprise [96, 100]. Another more recent
structure also suggests a dominant GxxxA motif, but with the TM helices interacting in a
right-handed orientation [102] (Fig. 4.1, center).
These differing views of the C99 homodimer structure raise important questions about
the interactions of APP homodimers and their structure. How does the structure of C99
homodimers depend on sequence and lipid environment? What is the structure of the C99
homodimer in a biologically relevant membrane bilayer environment? How does dimer-
ization of C99 influence its TM structure, helix stability, and availability to cleavage by
γ-secretase?
Building on prior computational and experimental studies, we have explored the homod-
imerization of C9915−55 in lipid bilayer environments using a multiscale modeling approach.
Our simulations demonstrate that the C9915−55 homodimer structure must be represented
by multiple states, characterized by the relative orientations of the TM helices and stabilized
by distinct intermolecular contacts. The relative probability of each substate is dependent
on sequence and membrane environment. The most important implication of our finding
is that the recognition and processing of the homodimer by γ-secretase is state-dependent,
and that changes in the substate distribution may be reflected in the product distribution
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of Aβ isoforms.
4.2 Methods
4.2.1 Choice of initial conditions
Initial conditions for the REMD simulations were taken from experimentally derived struc-
tures determined by NMR of C9915−55 in DPC micelles (PDB 2LLM in the absence of the
N-terminal caps) [67]. Monomer configurations were separated and randomly reoriented. To
study C9915−55 in POPC bilayer environment using both CG and all-atom models, initial
conditions were derived from high probability structures observed in the REMD and CG
ensembles, respectively. The POPC bilayer was generated using the CHARMM-GUI Mem-
brane Builder [75, 74] and modeled using the CHARMM36 all-atom lipid force field and
TIP3P water model [78, 79]. All systems included Cl− ions to maintain electroneutrality.
To construct the CG peptide and bilayer systems, VMD [68] was used to overlap the
coordinate files of the peptide and the pre-equilibrated lipid systems and delete the lipid and
water residues within 1.5Å of the CG peptide. The pre-equilibrated boxes were taken from
the Marrink website and definitions of all CG particles for the peptide were generated using
the Martinize.py script with the MARTINI forcefield for proteins [103]. The CG parameters
for lipids, ions, and W water molecules were as described in the MARTINI forcefield [59].
The protein transformations between CG and all-atom models were performed using Pulchra
[104]. To study the self association of C9915−55 dimers using a CG model, two C9915−55
CG monomers were initially separated by 45Å in a system of POPC lipids and W waters.
System sizes and sampling time scales are defined in Table 4.1.
4.2.2 Methods for simulation and analysis
The replica-exchange molecular dynamics (REMD) method was used in order to increase
conformational sampling [105]. Simulations were performed in CHARMM [78], with an
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Table 4.1: System sizes and time scales for implicit solvent, coarse-grained, and
all-atom simulations.
Lipids Waters Force field Time Structure
256 POPC 3863 W Martini 2.2 50 × 2µs C9915−55 + 45Å apart
Implicit Implicit CHARMM27+GBSW 24 × 10.5 ns α-helix + 20Å apart
128 POPC 7176 TIP3P Gly in (REMD)
128 POPC 7441 TIP3P CHARMM36 100 ns Gly out (CG)
128 POPC 7727 TIP3P Gly side (REMD)
all-atom model of the protein and implicit representation of the solvent and membrane
environments using the GBSW model [58]. The PARAM22 force field with the CMAP
correction was used, including corrections specific for the GBSW model with updated radii
[58]. The smoothing length used at dielectric boundaries was 0.6Å, with 24 radial integration
points, and a cutoff of 20 Å. The surface tension coefficient was set to 0.04 kcal/mol Å. The
membrane width was 42Å with a 10Å “head group” switching region at each end, leaving
a 22Å width as the membrane interior. The switching function for the head group region
varied from the interior dielectric constant value of 1 to the solvent region dielectric of 80.
The membrane was defined as a continuous slab in the XY-plane, normal to the Z-axis.
CG simulations in POPC bilayer consisted of 50 replicas that were each simulated
for 2 µs of "Martini time.” Non-bonded interactions were truncated using shift functions
(between 0.9 and 1.2 nm for Lennard-Jones interactions and between 0 and 1.2 nm for
electrostatics) [59]. The temperature of the system was set to 303 K using the Berendsen
weak coupling method [106] with a coupling time of 0.1 ps. An integration time step of 30
fs was used in all simulations. The pressure was set to 1 bar using a semi-isotropic coupling
with the Berendsen algorithm.
All-atom simulations in the POPC bilayer consisted of 100 ns of MD performed on each
all-atom system (following minimization and a short NVT and NPT equilibration with the
protein backbone fixed). The non-bonded interactions were truncated using shift functions
(between 0.9 and 1.2 nm for Lennard-Jones interactions and between 0 and 1.2 nm for
electrostatics). Long-range electrostatic interactions were calculated using the Particle Mesh
Ewald (PME) method [107] with a Fourier grid spacing of 0.12 nm. The pressure was set to 1
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bar using a semi-isotropic coupling scheme with lateral and perpendicular pressures treated
separately with coupling time 0.1 ps using the Parrinello-Rahman barostat methodology.
The temperature of the system was set to 303 K and regulated using the Nosé-Hoover
weak coupling algorithm [80]. The linear constraint solver (Lincs) method [108] was used
to constrain all bond lengths, with a 2 fs integration step. The simulations were carried
out using CHARMM [78] or GROMACS (v4.5.1). The analyses were performed using the
CHARMM or GROMACS packages, the DSSP program, and tailored scripts using Python
and MD Analysis libraries [76, 77, 109, 110, 111]. Images were generated using VMD [68].
All simulations were performed on the Boston University Katana and SSC supercomputers.
4.3 Results
We employed a multiscale modeling approach (see Fig. 2.1) by initially simulating C9915−55
homodimer using REMD and an all-atom model of the peptide in an implicit Generalized
Born with a simple Switching (GBSW) membrane environment. The membrane thickness
was chosen to approximate the thickness of an all-atom POPC bilayer, with the end-to-end
distance set to 42Å, and the center-to-center distance of the switching region set to 32Å.
These simulations were used to derive structural ensembles for C9915−55 homodimer that
were analyzed in terms of depth-of-insertion, tilt angle, and peptide helicity.
The REMD results informed the parameterization of a MARTINI coarse-grained (CG)
simulation model of the C9915−55 homodimer for use in microsecond simulations of the
C9915−55 homodimer in a POPC (1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine) lipid
bilayer. The simulated conformational ensemble was analyzed in terms of the homodimer
structure and the dependence on the membrane environment.
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Figure 4.2: Lipid density profiles derived from REMD simulations using an all-
atom CHARMMmodel of the peptides and implicit GBSWmembrane model (upper)
and CG Martini model MD simulations of the peptides in a POPC bilayer (lower).
Dashed lines indicate the center-to-center distance of the switching region (GBSW
simulation) or head group region (CG simulation) for each system.
4.3.1 C9915−55 homodimer consists of two helical domains with distinct
GG hinge in TM helix.
The computed lipid density profile and depth-of-insertion of key peptide residues for the
CG POPC bilayer is presented in Fig. 4.2, in comparison with results derived for an all-
atom peptide model in an implicit GBSW membrane model. The average width of the two
membranes is similar, although the lipid density profile is found to be slightly broader and
more diffuse in the CG particle model of the POPC bilayer. In spite of these differences
in the membrane profiles, the distributions of depth-of-insertion for key residues of the
peptides are quite similar in the implicit and CG models. This suggests that while the
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interfacial regions are different in structure, the depth-of-insertion of the residues is largely
determined by the tilt angle of the TM helix, which is largely determined by the average
membrane thickness and is similar in both models.
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Figure 4.3: Helicity of peptides in the C9915−55 homodimer ensemble simulated
(top) using all-atom simulation in an explicit POPC bilayer, and (bottom) using
REMD and an implicit GBSW membrane model. The grey shadow shows exper-
imentally determined helicity based on Cα NMR chemical shift measurements for
monomeric C991−55 in an LMPG (lysomyristoylphosphatidylglycerol) micelle [67].
The peptide helicity (see Fig. 4.3) derived from REMD simulations in an implicit mem-
brane model is consistent with data published previously for C991−55 monomer in a similar
implicit membrane model [100] as well as more recent all-atom simulations of C9928−55
homodimer in a POPC bilayer [29]. The results show a clearly defined TM helical region,
reduced helicity within the TM region near the dynamic GG hinge centered on G37/G38,
and a distinct but less stable N-terminal JM helix. Interestingly, peptide helicity in the
37
simulated C9915−55 homodimer is consistent with estimates derived from NMR studies of
C9915−55 monomer in an LMPG micelle. This suggests that homodimerization does not
impact peptide helicity in agreement with previous results of NMR studies of C9913−55
homodimer in detergent micelles [92].
4.3.2 Structural states of (C9915−55)2 characterized by relative orientation
of GxxxG repeat motifs.
Good order parameters for the homodimer structure are (1) dihedral angle φ4G formed
by G29A-G37A-G37B-G29B, where A and B label the two C9915−55 monomers, and (2)
interhelical distance dGG between G33A-G33B. The φ4G order parameter is positive for
left-handed structures and negative for right-handed structures. Structures stabilized by
interpeptide interactions facilitated by the GxxxG repeat region are characterized by small
values of dGG.
Peptide conformational distributions derived using REMD with an all-atom peptide
potential and implicit GBSW membrane model as well as the CG MARTINI model are
largely consistent for the two levels of modeling (see Fig. 4.4, top panels). In particular,
both models lead to overall conformational ensembles consisting of close (dGG ≈ 5Å), in-
termediate (dGG ≈ 10Å), and longer-range dGG interactions. Both models yield close dGG
interactions that can be right- or left-handed, but favor right-handed conformations. Also,
both models show a range of intermediate dGG values, including both right-handed and
left-handed structures.
An additional valuable order parameter for the evaluation of interhelical contacts is the
Crick angle, ψCrick, between (1) the vector connecting the axis points of the two helices
and (2) the vector connecting Cα of a given residue to its corresponding α-helix axis point
[112, 113, 114]. Smaller values (between 0 and 60) identify residues closer to the dimer
interface, while larger angles (close to 180) denote residues on opposite sides of the interface.
We define ψCrick to be the average of the G33 and G37 Crick angles in order to characterize
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Figure 4.4: C9915−55 homodimer populations derived from CG simulations with
POPC membrane (left panels) and REMD simulations with implicit membrane (right
panels) projected onto the order parameters φ4G and dGG. Upper panels show the
dGG - φ4G values while lower panels depict projections onto ψCrick angles. Scales for
all the graphs are on the right.
the G33xxxG37 interface.
The lower panels of Fig. 4.4 show projections onto the two peptide ψCrick angles. The
symmetry of the distribution above and below the diagonal demonstrates the goodness of
sampling achieved by both sets of simulations, as individual peptides forming the homod-
imer sample a similar range of conformations. The CG and implicit GBSW simulations
sample dimer structures consisting of the GxxxG motifs on both peptides facing the inter-
face (bottom left), both GxxxG motifs facing away from the interface (middle/top right),
and structures where the GxxxG motif of one peptide faces the interpeptide interface and
the other faces away (top left/bottom right). These distinct states can be characterized in
detail in terms of the relative peptide orientations and interpeptide contacts.
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4.3.3 (C9915−55)2 structural ensemble consists of three distinct conforma-
tional states
The structural ensemble has a number of important characteristics. The predominant
topology of the homodimer is a right-handed coiled-coil with three populated states which
can be generally characterized in order of relative prominence (see Fig. 4.5).
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Figure 4.5: All-atom simulation results for the averaged ψCrick angles for conforma-
tions representing states Gly-in (top), Gly-out (center) and Gly-side (bottom), shown
alongside characteristic structures derived from all-atom simulations in a POPC bi-
layer. Key glycine residues are shown in shades of green, residues V40 and A42
are shown in yellow and orange, respectively, and C-terminal threonine residues are
shown in purple.
(1) “Gly-in” configurations (smallest dGG in Fig. 4.4, upper) are characterized by close
interpeptide contact facilitated by exposure of backbone carbonyls in the GxxxG repeat
region. This structural motif is defined by "in phase" values of ψCrick (see Fig. 4.4, lower)
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stabilized by contacts at an interface formed by G29, G33, and G37 (small values of ψCrick
in Fig. 4.4), allowing V40 to remain near the interface while A42 faces outside (large value
of ψCrick in Fig. 4.4). In addition, T43, I47, and a “lysine-zipper” stabilize interpeptide
contacts in the C-terminal domain of the TM helix.
(2) “Gly-side” configurations (intermediate dGG in Fig. 4.4) are characterized by sub-
stantial interhelical contact and interpeptide interactions involving hydrophobic residues
Leu34 and Met35 that interact to form a zipper-like structure. This structural motif is
defined by "out of phase" values of ψCrick (see Fig. 4.4). In this conformation, the I32,
V36, V40, T43, and I47 side chain contacts form the interpeptide interface. These bulky
hydrophobic side chains cause the backbones to be farther separated in a state that may
serve as an “intermediate” in transitions between Gly-in and Gly-out states.
(3) “Gly-out” configurations (largest dGG in Fig. 4.4) are characterized by glycine repeats
facing the outside of the homodimer interface (large values of ψCrick in Fig. 4.4). In this
conformation, I32, V35, and V39 side chain interactions stabilize an X-like homodimer
structure (as was observed in recent NMR experiments). A larger interpeptide separation
in the N-terminal region of the TM helix allows for close contact between G38 and A42/T43
that mediates the dimeric Gly-out interaction in the C-terminal region of the TM helix.
4.3.4 Membrane fluctuations influence the different states of (C9915−55)2
In order to better understand the effect of the environment on dimer structure, CG results
were filtered based on local membrane fluctuations through the simulation. Separation of
the CG dimer structures by their local hydrophobic core (defined by the 10Å hydrophobic
section around the x and y center of geometry of the dimer), shows a direct correlation be-
tween the membrane width and the population of the different structural states. As shown
in Fig. 4.6 (left), smaller hydrophobic cores increase the population of Gly-out conforma-
tions, while wider hydrophobic cores favor Gly-in conformations.
This trend was also seen in REMD simulations when simulations in the 42Å membrane
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were compared to results from simulations run using narrower membrane parameters. In
Fig. 4.6 (right), sampling in the smaller 40Å membrane shifts significantly to favor the
Gly-side and Gly-out dimer states.
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Figure 4.6: Left: Population of Crick angles in the CG simulation filtered by
local membrane widths. Yellow clusters correspond to a local hydrophobic core (hc)
smaller than 36Å, red to a local hc between 38 and 39Å, and blue to a local hc wider
than 39Å. Right: Population of Crick angles from two separate REMD simulations;
one in a 42Å membrane (red), and the other in a 40Å membrane (yellow).
Fig. 4.7 shows the fractional helicity by residue for the TM helix in each cluster in both
all-atom and REMD simulations. Both CG and all-atom results suggest that the average
helicity is similar in all states. In each case, there is a drop in helicity near the G37/G38
hinge, as well as a strongly helical nature that diminishes near V50, which is the site of
initial cleavage by γ-secretase. These findings together suggest that changes in the dimer
interface are not due to structural changes in the TM domain, but rather are an effect of
the local membrane environment.
The three substates (Gly-in, Gly-side, and Gly-out) are characterized by distinct kink
and tilt values (Fig. 4.8). The kink angles were calculated as the angle between the N-
terminal and C-terminal portions of the TM helix (above and below residues G37/G38).
The TM angle was calculated for the N-terminal portion of the TM helix, with the angle
indicating the deviation from the membrane normal. In the Gly-in substate, both peptides
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Figure 4.7: The helicity observed in the different all-atom simulation of C9915−55
homodimer in a POPC bilayer (left) and REMD simulations in a GBSW membrane
model (right). From top to bottom are Gly-in, Gly-side and Gly-out.
display a moderately kinked TM helix (kink angles up to ≈30-35 degrees) and one peptide
is characterized by a larger tilt angle. The Gly-side structures are characterized by both
peptides in the homodimer having relatively low kink and tilt angles, while the Gly-out sub-
state is observed to contain both heavily tilted peptide, and one peptide having moderately
larger kink values. These might indicate a possible mechanism for the effect of the bilayer
environment on the dimer interface, where repositioning of the peptides to accommodate
varying bilayer widths imposes steric effects as the homodimers interact with each other.
Wider membranes would bias the peptides towards less tilted conformations, with the fa-
vorable right-handed GxxxG interactions requiring the peptide to coil around each other,
yielding higher kink values. Intermediate membrane widths attenuate these interactions,
decreasing the kink angles in the peptides. Narrow membrane widths require both peptides
to tilt heavily to avoid hydrophobic mismatch of the peptides in the bilayer.
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Figure 4.8: The kink and tilt angles observed in the different all-atom simulation
of C9915−55 homodimer in a POPC bilayer. Left and right sides show results for each
peptide in the homodimer, respectively. From top to bottom are Gly-in, Gly-side
and Gly-out. Color indicates the dGG value in angstroms.
4.4 Discussion
It has been proposed that dimerization of the C99 transmembrane domain is a consequence
of intermolecular interactions facilitated by GxxxG motif repeats [36]. This motif also
promotes a right-handed crossing in JM helices by providing a good surface for packing
and permitting close helix proximity [115]. The earliest proposed structures for the ho-
modimer of the TM region of C99 were right-handed coiled-coil structures stabilized by
favorable interactions at the interpeptide interface facilitated by the GxxxG motif. In con-
trast, two recently proposed NMR structures (PDB:2LOH [92], and 2LZ3 [116]) of the C99
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TM sequence consist, respectively, of a left-handed and right-handed coiled-coil structure
stabilized by interpeptide contacts facilitated by the G38xxxA42 repeat motif, which would
correspond to a Gly-out orientation.
It is important to note that experimental studies of C99 were performed in a variety of
lipid environments, including DMPC and DMPG membrane bilayers [98], LMPG micelles
[67], DPC micelles and DMPC/DHPC bicelles [92], and neuronal cell systems [54] among
others. It has been proposed in many of these studies that C99 is sensitive to the lipid
environment, and that both its structure and cleavage can be affected by changes in the
environment [36, 67, 90].
In this study, we find that C9915−55 homodimers consist of an ensemble of structures,
stabilized by varying interfaces, including both GxxxG and GxxxA motifs that have been
previously characterized experimentally. Although the dimers favor a right-handed coiled-
coil packing, left-handed structures exist within the ensemble as well. Furthermore, we find
that the sampling of these states is strongly correlated to the local membrane fluctuations,
with narrower bilayers yielding a Gly-out orientation stabilized by the more C-terminal
GxxxA motif, and slightly wider membranes adopting the originally proposed Gly-in struc-
ture characterized by close packing of the N-terminal GxxxG repeats.
We believe that the strong sensitivity of the dimer structures to changes in the local
hydrophobic environment - on the order of a few angstroms - yields insight as to why
experimental studies performed in a variety of micelle and bilayer systems of differing lipid
compositions result in such contrasting dimer structures that involve different residues at
the interface and expose different residues at the homodimer surface. This suggests a
possible mechanism for how varying lipid composition, as well as the presence of cholesterol
might affect local membrane character, and thus the structure and processing of C99 dimers
[67, 90]. Our work suggests a possible mechanism for “environmental-selection” of specific
C99 homodimer substates, even before consideration of possible specific peptide-cholesterol
interactions.
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Chapter 5
Impact of membrane lipid composition on the structure and
stability of homodimers of the transmembrane domain of
Amyloid Precursor Protein 1
5.1 Introduction
Understanding the structural and thermodynamic properties of transmembrane helical
dimers is of fundamental importance to molecular biology. It is known that the association
of "biotopic" proteins, having single transmembrane (TM) helical domains, is essential to
immunoreceptors and protein kinases that play critical roles in cellular function. Insights
from computation and experiment have since led to an appreciation for the role of sequence-
specific interactions stabilizing helix dimerization [117]. Of particular interest is the role
of the GxxxG motif in stabilizing TM helix-helix association in systems including the gly-
cophorin A (GpA) homodimer [56, 118], found in the human erythrocyte membrane, and
APP-C99 (C99), the 99 amino acid C-terminal fragment of the amyloid precursor protein
[98, 100].
The amyloid β (Aβ) peptide aggregation pathway, known to be critical to the evolution
of Alzheimer’s Disease, begins with the cleavage of APP-C99, by γ-secretase leading to
formation of Aβ. The formation of homodimers of APP-C99 has been proposed to be
critical to the processing by γ-secretase, a process that is known to depend on a number
of factors including peptide sequence and lipid composition of the membrane environment.
Knowledge of the structure and stability of the APP-C99 (C99) homodimer is therefore
critical to our understanding of the Aβ peptide aggregation pathway.
The first simulation of an equilibrium structural ensemble of the homodimer of the
1All coarse-grained and all-atom simulations and analysis in this chapter were performed by Dr.
Laura Dominguez.
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TM helical region of C99, C9923−55, was performed using replica exchange molecular dy-
namics (REMD) simulation and an implicit membrane model [100]. The structure of the
WT homodimer was found to be a λ-like right-handed coiled-coil structure stabilized by
interpeptide Cα hydrogen bonds, mediated by interactions between GxxxG motifs. Of the
three contiguous GxxxG motifs in the WT peptides the Cα hydrogen bonds involving Gly33
and Gly38 were observed to be most essential in stabilizing the WT dimer. The simulated
structural ensemble was in good agreement with the proposed solid state NMR structure
[98] while providing more detailed insight into the structural ensemble of the dimer in a
fluid membrane environment.
Additional support for this structural motif for the homodimer was provided in a recent
study involving H/D exchange experiments on the C99 peptide complemented with molec-
ular dynamics simulations of the TM region, C9928−55, in a POPC bilayer. That study
also provided detailed insight into the stability of helical regions of C99 including the TM
helix. It was found that the portion of the TM helix on the N-terminal side of the G37/G38
“kink” was more dynamic and showed enhanced H/D exchange relative to the C-terminal
portion of the TM helix [29]. That finding is in agreement with prior studies of the C99
monomer in LMPG micelles. It is also in agreement with prior simulation studies [100] of
the WT C9923−55 homodimer demonstrating that the region of the peptide including the
GxxxG repeats was significantly less helical than the C-terminal portion of the TM helix,
allowing for close interpeptide backbone association and Cα hydrogen bonding stabilizing
the homodimer [100].
In addition, a recent NMR study led to the first experimentally derived structure of
the homodimer formed by the TM helical domain, C9923−55[92]. In contrast to earlier
computational modeling and simulation predictions, the proposed structure is a X-like left-
handed parallel dimer stabilized through interactions involving an extended heptad repeat
motif TM helical region. This study raises additional questions related to the peptide
environment, focusing on how factors such as micelle size and interfacial curvature might
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influence peptide structure[119, 120, 121].
Importantly, an NMR study of C991−55 in membrane environments of variable lipid
composition clearly demonstrated that fluctuations in the TM helix can be a strong func-
tion of membrane composition [36]. Changes in membrane composition may modulate the
physical boundaries of the bilayer, including width and structure of the interface, as well
as the chemical nature of the head group region and membrane interior. While it is clear
that C99 peptide structure depends on membrane compositions, the role of these various
physical-chemical parameters in influencing the peptide structure is not understood.
To explore these important open questions, we have performed a detailed simulation
study of the structure and stability of the homodimer of the TM domain of APP-C99 using a
multiscale computational model. This approach aspires to use atomistic and coarse-grained
representations of the peptide and lipid system self-consistently, in a manner that allows for
the study of the homodimer structure and its dependence on membrane composition. Our
results provide a detailed picture of the C9923−55 structural ensemble, its dependence on
membrane composition, and the potential role for changes in structure to influence function
of this critical amyloid precursor protein.
5.2 Methods
A multiscale computational approach was employed, as described in Chapter 2 combining
implicit replica exchange MD (REMD) simulations [57], coarse-grained models of the pro-
tein, lipids, and solvent using the Martini force field [59, 60], and all-atom representations
of the protein using all-atom CHARMM and GROMOS force field models for the protein,
membrane, and solvent environments [61, 62, 63, 64].
Initial conditions for the homodimer simulations were taken from experimentally derived
structures determined by NMR of C99(15−55) in zwitterionic dodecylphosphocholine (DPC)
micelles (PDB 2LLM) [92]. Additional initial conditions were taken from experimentally de-
rived monomeric structures determined by NMR of C99(1−55) in lyso-myristoylphosphatidylglycerol
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(LMPG) micelles (PDB 2LMT) [67, 90]. The initial structures for the coarse-grained simu-
lations of monomers and dimers were generated using a mapping from the NMR and REMD
simulations. The structures were embedded in pre-equilibrated coarse-grained lipid bilayers
of varying composition, including pure DMPC, pure DPPC, pure POPC, and POPC/DOPE
1:1 (mol:mol) mixture.
Table 5.1: System sizes and time scales for implicit solvent, coarse-grained, and
all-atom simulations.
System Time Bilayer Force field
2 × C9923−55 10 ns Imp 27 Å REMD CHARMM27
2 × C9923−55 10 ns Imp 30 Å REMD CHARMM27
2 × C9923−55 10 ns Imp 32 Å REMD CHARMM27
2 × C9923−55 10 ns Imp 35 Å REMD CHARMM27
2 × C9923−55 10 × 1.5 µ s DMPC MARTINI2.2
2 × C9923−55 10 × 1.5 µ s DPPC MARTINI2.1
2 × C9923−55 10 × 1.5 µ s POPC MARTINI2.1
2 × C9923−55 10 × 1.5 µ s POPC/DOPE MARTINI2.1
C9923−55dim(A) 100 ns POPC CHARMM36
C9923−55dim(B) 100 ns POPC CHARMM36
The replica-exchange molecular dynamics (REMD) simulations were performed using
the CHARMM22 force field [122], with an all-atom model of the protein combined with
an implicit representation of the solvent and membrane environments using the GBSW
model [58]. In the coarse-grained simulations, non-bonded interactions were calculated
within a cutoff of 1.2 nm using shift functions (between 0.9 and 1.2 nm for Lennard-Jones
interactions and between 0 and 1.2 for electrostatics) [59]. The temperature of the systems
was set to 325 K using the Berendsen weak coupling method [106] with a coupling time of
0.1 ps. The pressure was set to 1 bar using a semi-isotropic coupling scheme with lateral and
perpendicular pressures coupled separately with coupling time 0.1 ps and compressibility
of 2×10−5 bar−1 [106]. An integration time step of 30 fs was used in all simulations. For
the all-atom simulations, the short range electrostatics was cut-off at 1.2 nm. PME was
used to calculate the long-range electrostatics interactions. To control the temperature
and pressure, the Nosé-Hoover (16) thermostat and the Parrinello-Rahman barostat were
employed. Simulations details for all systems are shown in Table 5.1.
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5.3 Results
Conformational distributions were derived from both replica-exchange molecular dynam-
ics (REMD) or coarse-grained (CG) molecular dynamics simulations. REMD simulations
consisted of 16 replicas spanning temperatures from 300-550K with 10 ns of simulation for
each replica (160 ns total simulation time) for each system. C9923−55 homodimer systems
were simulated in four different GBSW implicit membrane widths: 27, 30, 32, and 35 Å,
respectively. Starting configurations sampled a variety of dimer interfaces, with the pep-
tides placed 25 Å apart. CG simulations were performed using 10 replicas with 1.5 µs of
dynamics for the C9923−55 homodimer in DMPC, DPPC, POPC, and 50:50 POPC/DOPE
bilayers. The two monomers were initially placed at a separation of 50 Å and allowed to
associate.
5.3.1 Conformational ensemble of C9923−55 homodimer consists of mul-
tiple conformational substates
Important order parameters used to characterize the homodimer ensemble include the di-
hedral angle formed by G29-G37-G37-G29 (φ4G), which differentiates right-handed (negative
values) and left-handed (positive values) coiled-coil geometries, and dGG distance, where
close distances indicate interpeptide contacts in the GxxxG repeat region. Simulations of
the homodimer were analyzed using a projection of the homodimer ensemble on the the φ4G
angle and the dGG distance between the homodimers in bilayers of varying lipid composition
(Fig. 5.1).
We identify three populated substates that contribute to the homodimer ensemble. The
conformations within each substate are uniquely identified in terms of one of three different
packing interfaces. (1) The most populated configuration ("Gly-in") is stabilized by Gly-
Gly interactions in which the residues of the φ4G repeat face the inside of the homodimer
structure with dGG distances of 5 Å and φ4G angles of <-25 degrees. (2) The next most
populated ("Gly-side") substate is defined by stabilizing interpeptide interactions involving
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Figure 5.1: Conformational distributions derived from CG MD simulations. While
the overall conformational ensemble is dominated by right-handed coiled-coil confor-
mations for each bilayer, the lipid composition is observed to modulate the relative
stability of competing substates in the homodimer structural ensemble. Colors indi-
cate relative population distributions.
the hydrophobic residues Leu34 and Met35 that interact to form a zipper-like structure (with
glycine facing the side of the homodimer interface). (3) The least populated ("Gly-out")
substate is characterized by having the glycine repeats facing the outside of the homodimer
interface leading to stabilization of the homodimer by hydrophobic interpeptide interactions
with dGG distances of 12 Å.
Fig. 5.1 and Fig. 5.2 display the probability distributions for the φ4G angle and dGG
distance for the C9923−55 homodimer in four different CG and implicit membrane systems,
respectively. While right-handed homodimers are dominant in all membrane compositions,
there are notable changes in the relative probability of the three conformational substates
that compose the homodimer’s conformational ensemble. In particular, in moving from the
shortest to longest alkyl chains in saturated DMPC, saturated DPPC, and monounsaturated
POPC, and finally to the mixture of POPC and diunsaturated DOPE, there is a dramatic
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Figure 5.2: Conformational distributions derived from REMD simulations. The
simulations favor right-handed structures at lower dGG values, although structures
with larger dGG values also sample left-handed structures. The relative sampling
of each substate shifts as the width changes, with the 32 Å membrane homodimer
structural ensemble strongly dominated by the Gly-in state. Colors indicate Free
Energy in kcal/mol.
shift in populations of the three homodimer substates. This same shift is reflected in the
implicit membrane systems as the GBSW membrane width is increased.
5.3.2 Membrane lipid composition modulates competing C9923−55 ho-
modimer substates
The shift in substate populations can be understood in terms of the lipid density profiles
for the four bilayers (see Fig. 5.3). In the thinnest membrane systems, DMPC (CG) /
27 Å (GBSW), the homodimer has the broadest distributions of φ4G angle, and the most
substantial populations in the "Gly-out" substate. As the lipid composition is varied and
the membrane width increased, there is a transition to an increasingly sharply defined value
of φ4G angle and enhanced population of the "Gly-in" substate. For the thickest membrane,
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POPC/DOPE, there is a strong preference of the "Gly-in" substate that is consistent with
the earliest predictions of the C9923−55 homodimer structure. However, we see that the
particular homodimer structure, and the intrinsic disorder in the conformational ensemble,
is a strong function of membrane composition.
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Figure 5.3: Lipid density profiles derived from CG MD simulations in four bilayer
lipid compositions (from the top) DMPC, DPPC, POPC, and 50:50 POPC/DOPE.
In clear support of this observation, the tilt angle distribution (see Fig. 5.4) shows a
dramatic increase of ≈20 degrees for states sampled by homodimers in the 27 and 30 Å
implicit membrane as opposed to the 35 Å system (where the tilt angle samples a narrow
distribution centered around 20 degrees).
5.3.3 Homodimer substate population is a sensitive function of mem-
brane width
Although the homodimer systems in Fig. 5.2 sample many similar φ4G and dGG values,
systems in varying membranes do not necessarily adopt the same structures. Fig. 5.5
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Figure 5.4: Peptide kink and tilt angle distributions derived from REMD sim-
ulations. Top: C9923−55 homodimer systems, with angles are averaged over both
peptides. Bottom: C9923−55 monomer. Colors indicate Free Energy in kcal/mol.
presents values for the same order parameters for the lowest energy replica in each implicit
membrane system now colored by the maximum peptide kink angle in the homodimer. The
average peptide kink varies substantially with the membrane width parameter (Fig. 5.4).
Comparing the distributions for the 27 Å and 35 Å membranes in Fig. 5.5 one can see clear
differences between clusters with similar dGG/φ4G value. Structures in the 27 Å membrane
display significantly higher maximum kink angles, nearly 90 degrees, whereas the same
cluster in the 35 Å membrane has a maximum kink angle around 30 degrees.
5.3.4 Helicity of C9923−55TM helix is enhanced by homodimer formation
In order to develop a detailed atomistic description of the protein-protein interactions of
the most probable CG homodimeric structures, we performed all-atom molecular dynamics
simulation using the CHARMM force field in a variety of lipid membranes and analyzed
the resulting structural distributions. Initial structures were chosen from the result of CG
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Figure 5.5: Distributions derived from REMD simulation of C9923−55 homodimer
systems in varying implicit GBSW membranes. Results derived from the lowest
energy replica of each system are plotted by (top) φ4G and dGG values and (bottom)
ψCrick angles. Color indicates the value of the maximum kink angle in the homodimer.
MD simulations representing the "Gly-in" and "Gly-out" substates in a POPC membrane.
Using Pulchra [104] we transformed the initial coarse-grained structures to all-atom models,
which were embedded in a POPC membrane using CHARMM/GUI. The structures were
minimized and pre-equilibrated at 303 K and 1 atm while restraining the protein back-
bone, followed by a production run in the absence of restraints under a NPT semiisotropic
ensemble using CHARMM36 all-atom lipid force field (with CMAP) and TIP3P water.
Our all-atom simulations confirm that the secondary structure of C9923−55 is predom-
inantly helical as a monomer and as a homodimer (Fig. 5.6). The root-mean-square fluc-
tuation in the TM helix of the monomeric peptide is consistent with experimental data
presenting the largest motion near Gly 39 [90]. We detect an enhancement in the helicity
of the TM region in the homodimer relative to the monomer. It appears that fluctuations
in the monomeric peptide, particularly near the proposed "kink" region of the TM helix,
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Figure 5.6: The average helicity derived from all-atom simulation of C9923−55
monomer (red) and homodimer (blue) in a POPC bilayer using an all-atom model.
The grey shadow shows experimentally determined helicity based on NMR chemical
shift measurements for monomeric C991−55 in an LMPG micelle [67].
reduce helicity in the monomer while being somewhat suppressed by interpeptide contacts
in the homodimer.
5.3.5 Other transmembrane helix-helix interactions
Among other transmembrane proteins, glycophorin A (GpA) dimerization has also been
proposed to be a consequence of interactions facilitated by GxxxG motif repeats forming
right handed coiled-coils [118, 117, 65]. However a diversity of structures of coiled-coils
interactions have been found in TM helices: homo- or hetero-dimers with right or left-
handed crossing angle between the helices and dynamic conformations of TM helix dimers
have been proposed to be essential for physiological function of TM proteins [123, 124, 125].
An interesting coiled-coil TM helix is the human EphA2 receptor tyrosine kinase because it
has been proposed that its dimeric conformation is affected by the thicknesses of the lipid
bilayer; in thick bilayers EphA2 TM forms a left-handed (+15) TM dimer stabilized via an
heptad repeat motif while in thiner membranes the EphA2 TM dimer is characterized by a
glycine zipper motif and a right handed (-45) crossing angle between the helices.
We carried out CG simulations of EphA2 homodimer in bilayers of varying lipid com-
position (see. Fig. 5.7) to compare with trends observed in our simulations of the C9923−55
homodimer. We observe structures consistent with both the "Gly-in" and "Gly-out" sub-
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Figure 5.7: Conformational distributions derived from CG simulation of EphA2 ho-
modimer systems in bilayers of varying lipid composition, plotted by (top) φ4G and
dGG values and (bottom) ψCrick angles. Color indicates relative probability. Sub-
stantial dependence of the homodimer structure, including variations in handedness
of the coiled-coil, on bilayer lipid composition is observed.
states, with an overall ensemble that is dominated by right-handed coiled-coil structures.
Moreover, the same substates forming this structural ensemble are observed in four differ-
ent membrane environments. These results based on a multiscale modeling approach that
accounts for a detailed picture of the protein-lipid interactions provides clear support for
the dominance of the right-handed coiled-coil structure for the WT C9923−55 homodimer
in a lipid bilayer. The simulations further suggest that lipid composition may be critical
in determining the degree of helicity in the transmembrane region, which appears to be
enhanced in the homodimer relative to the monomeric peptide.
5.4 Discussion
Lipid composition of membranes has been shown to impact the structure and stability
of C99 homodimers as well as the integrity of the TM helical region in the monomeric
peptide. Our multiscale simulations have explored the structure of the C9923−55 monomer
and homodimer in bilayer membranes as a function of varying lipid composition. Overall,
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our results suggest that a multiscale approach to modeling TM helical association in lipid
bilayers, critical to biomolecular signaling and processing, can provide critical insight into
the relationship between protein structure and function.
Our results support earlier simulation predictions, based on simplified models or limited
experimental information, that the homodimer structure of C9923−55 is a right-handed λ-like
coiled-coil stabilized by interpeptide interactions. However, we also find that the particular
lipid composition of the membrane impacts the bilayer width which biases the TM helix tilt
orientation of the monomeric C9923−55 structure in the membrane. Our simulations identify
three conformational substates that define the overall right-handed coiled-coil homodimer
ensemble. The particular importance of one substate relative to another is modulated by
the lipid composition of the membrane bilayer. Results for C9923−55 homodimer structure
derived from REMD simulations in implicit membrane of varying thickness are in qualitative
agreement with trends observed CG simulations of C9923−55 homodimer in explicit bilayers
of varying lipid composition (see Figs. 5.2 and 5.7).
The trends observed in the structural ensemble of the C9923−55 homodimer as a function
of lipid membrane composition also provides a partial explanation for the recently observed
NMR structure of the C9915−55 homodimer in a DPC micelle [92]. That structure was
observed to have a "Gly-out" structure that differed from the previously proposed "Gly-in"
structures that were based on simulation and solid-state NMR data [54, 51, 98, 100, 91]. The
surfactant forming the DPC micelle is most similar in structure and alkyl chain length to
the DMPC lipid, which was found to form the thinnest of the four lipid bilayers studied. In
that thin membrane, the tilt angle was enhanced and the "Gly-out" structure significantly
enhanced over the structural ensembles observed in the thicker bilayers. Therefore, the
"Gly-out" configuration observed experimentally may, at least in part, reflect the relative
restraints of the "thin" micelle in which the C9923−55 homodimer was studied.
It has been observed that membrane thickness is a crucial factor in the processing of
APP by γ-secretase that can impact the overall production of Aβ peptide and the ratio of
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Aβ40 : Aβ42. Our results demonstrate that membrane composition can influence membrane
thickness, which can both alter the depth of insertion of the peptide into the membrane and
impact the termination of processive cleavage of the TM helix by γ-secretase. Moreover, our
results demonstrate that membrane lipid composition can impact the structure and stability
of the C99 homodimer, with thicker membranes stabilizing "Gly-in" conformations, another
factor that has been shown to impact the processing of C99 by γ-secretase.
59
Chapter 6
Flemish A21G familial Alzheimer’s Disease mutation alters
APP-C99 homodimer interface
6.1 Introduction
According to the Amyloid Cascade Hypothesis, accumulation of amyloid β (Aβ) is the
crucial event leading to the development of Alzheimer’s Disease (AD) [8, 81]. A key step
in the “cascade” is the processing of Amyloid Precursor Protein (APP) to generate the Aβ
peptide. APP is a type I transmembrane protein of lengths ranging from 365 residues to the
more common 770 residues [14, 7]. In the amyloidogenic pathway, APP is initially processed
at the N-terminus of Aβ by β-secretase [15, 17], releasing a large extracellular domain and
leaving behind a membrane-bound 99-residue long fragment. This fragment, known as C99,
undergoes multiple sequential cleavage events by the protein complex γ-secretase, beginning
at the ǫ-processing and progressing up the TM helix to the final γ site, which releases the
resulting Aβ protein [22, 24, 25].
Two main pathways have been identified for this cleavage mechanism: one beginning
with ǫ-cleavage at residue L49 and progressing to Aβ40 cleavage, the other with the ǫ-site
shifted to residue T48, generating Aβ42 [29]. What influences the favorability of one path-
way over the other remains an open question, however many known Familial Alzheimer’s
Disease mutations (FAD) have been shown to alter the ratio of Aβ42/Aβ40, leading to
early onset of AD [85, 87].
In 1992, researchers identified a new FADmutation, coded by a C→G base pair mutation
at exon 17 [44]. This mutation was associated with an early onset of AD (≈46 years of
age), and was accompanied by cerebral haemorrhage and early age of death. This Flemish
mutation - A21G substitution on the C99 protein - has been suggested to operate by a
60
different mechanism than many other characterized FAD mutations. The A21G mutation
has been demonstrated to increase production of both Aβ40 and Aβ42 by amounts ranging
from a two- to four-fold increase [45, 126, 91]. Proposed theories include that A21Gmutation
creates a better substrate for γ-processing, or that the central hydrophobic cluster (CHC)
on the Aβ strand (residues L17V FFA21) acts as a γ-secretase inhibiting region and that
mutation at residue 21 reduces inhibition [126, 91].
The A21G mutation has also been investigated for its effect on APP dimerization [91].
The APP strand contains GxxxG repeat motifs which have been shown though both sim-
ulation and experiment to enhance dimerization by enabling close interpeptide contacts
[54, 53, 29, 100, 121]. The WT sequence features three sequential repeats of this motif:
G25xxxG29xxxG33xxxG37. The A21G mutation extends this motif by one repeat, and
adds the G21xxxG25 sequence, and a recent study suggested that the A21G mutation
might be responsible for a change in the dimer interface along the GxxxG repeats [91].
To investigate the effect of A21G substitution on the structure of APP-C99 homodimers,
we carried out simulations of C9915−55 systems: WT and A21G mutants using a multiscale
approach. Homodimers were simulated both in an implicit environment using the replica
exchange (RE) method and in POPC bilayer. We hope to provide a better understanding
of the effect of the A21G mutation to the structure and dimerization of C99, in order
to characterize effects on the C99 system itself as opposed to possible effects on direct
interactions with γ-secretase caused by the amino acid substitution.
6.2 Methods
6.2.1 Multiscale Simulation
As described in Chapter 2, this study employed a “multiscale” approach consisting of replica-
exchange molecular dynamics (REMD) [57] simulations in a GBSW implicit membrane
environment [58], as well as all-atom simulation in a POPC bilayer. The combination of
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these methods allows for detailed investigation of the role of sequence in peptide structural
ensembles. First, comprehensive sampling is obtained using the REMD method, where
noninteracting replicas are simulated across a range of temperatures and allowed to attempt
exchanges between neighbors at certain time steps according to the Metropolis criterion [57].
Assuming adequate overlap between energy distributions at adjacent temperatures, replicas
are free to diffuse across the temperature space, allowing them to escape local minima and
perform adequate sampling of the conformational space of the peptides.
Characteristic structures from the REMD simulations are then used to seed all-atom
simulation in explicit lipid and water environments. This allows for detailed investigations
of specific structural features, as well as water-peptide and lipid-peptide interactions which
are lost in the implicit GBSW model.
6.2.2 Initial homodimer structure
Each peptide in the WT C9915−55 peptide homodimers consisted of the sequence:
Q15KLVFF20AEDVG25SNKGA30 IIGLM35VGGVV40IATVI45VITLV50MLKKK55
Starting structures for each peptide were taken from experimentally reported structures
derived with NMR studies of C9915−55 in DPC micelles (PDB 2LLM without N-terminal
caps) [67]. The homodimers were constructed by taking the separate peptide chains and
rotating them to sample a variety of initial interfaces between the peptides. Each generated
homodimer structure was minimized and oriented along the membrane normal. In addition
to the wild-type peptide, the A21G mutant was investigated, where the alanine at residue 21
(shown in bold) was replaced by a glycine residue. The point mutation was constructed in
VMD [68], and the resulting homodimers were minimized in CHARMM before equilibration
and production runs.
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6.2.3 Simulation Parameters and Force Fields
REMD simulations were carried out using the MMTSB tool set [72]. 24 replicas were used,
spanning a temperature range of 300 to 650 K. The MD timestep was set to 2 fs, with
the timestep for neighboring replicas to attempt exchanges set to every 0.5 ps. The total
simulation time for the WT system was 252 ns (10.5 ns/replica), and total simulation time
for the A21G system was 192 ns (8 ns/replica). The last half of the simulations were used
for analysis for both systems to avoid any dependence on initial conditions.
REMD simulations were performed in CHARMM [69] using an all-atom model of
the protein, and implicit representation of the solvent and membrane environments us-
ing the Generalized Born model with a switching function (GBSW) [58]. The proteins were
modeled using the CHARMM PARAM22 force field with dihedral cross-term corrections
(CMAP) [70], and with corrected atomic radii for the GBSW model [71]. At the dielectric
boundaries, a smoothing length of 0.6 Å was used, with 24 radial integration points, and a
cutoff of 20 Å. The surface tension coefficient was set to 0.04 kcal/(mol · Å2). The mem-
brane was set to a total width of 42 Å, with 10 Å at each end defined as the “head group”
switching region. This left a total of 22 Å as the membrane interior, where the dielectric
value was set to 1. The switching function for the head group region then varied from the
interior value to the solvent region, with a dielectric value of 80. The membrane was defined
as a continuous slab in the xy-plane, with the membrane normal along the z-axis.
Representative frames were selected from clustering analysis of the REMD results and
used as “seed structures” for all-atom simulations performed in GROMACS [76, 77] using
the CHARMM36 protein and lipid force field, and the TIP3P water force field [78, 79].
Homodimer structures were embedded into pre-equilibrated POPC bilayers consisting of
128 lipid molecules (64 each on the top and bottom layers), completed with the addition
of TIP3P water molecules extending 20 Å on each side of the bilayer, and six chloride
counterions to establish electroneutrality. The full systems were constructed using the
CHARMM-GUI [73, 74, 75]. All structures were subjected to steepest descent minimization,
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followed by 100 ps of NVT and 2 ns of NPT equilibration before being simulated for 100 ns,
with the initial 50 ns excluded from analysis. All equilibration and simulation used a time
step of 2 fs, PME to calculate long-range electrostatics, with short-range electrostatics cut
off at 1.0 nm. A Nosé-Hoover thermostat was used along with a Parrinello-Rahman barostat
to control the temperature and pressure [80].
6.3 Results
6.3.1 A21 mutation alters homodimer peptide-peptide interactions
In order to adequately sample the configurational ensemble of the peptides, REMD simu-
lations in an implicit GBSW membrane [58] were performed for both the wild-type (WT)
and A21G mutant C9915−55 systems. While specific lipid-protein interactions are lost in
the implicit membrane model, the REMD method allows for comprehensive sampling of
peptide-peptide interactions within the homodimer system [57] in order to provide a vari-
ety of starting structures for all-atom simulation.
In order to characterize the dimer interface, two main approaches were used: (1) projec-
tion onto the dGG and φ4G order parameters, and (2) the ψCrick angles for the homodimers.
The distance (dGG) is calculated between residues G33 on each peptide in the homodimer,
and the φ4G angle is given as the dihedral angle between residues G33A-G37A-G37B-G33B
where A and B indicate the respective peptides. Negative φ4G values indicate right-handed
coiled-coil interactions, while positive values indicated left-handed interactions.
Mutation at residue A21 has a clear effect on the peptide-peptide interactions involved
in the dimer interface (Fig. 6.1). Whereas the WT system features dominant right-handed
Gly-in interactions (small dGG values), the A21G ensemble samples more broadly from a
variety of substates, including both left- and right-handed interactions at a range of dGG
values.
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Figure 6.1: Conformational distributions of C9915−55 in implicit membrane derived
from REMD simulations for the WT (left) and A21G (right) C9915−55 sequences,
projected onto key order parameters: (top) dGG and φ4G values and (bottom) ψCrick
angles.
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Figure 6.2: Distributions of C9915−55 peptides in POPC bilayer derived from all-
atom simulations, showing projection of each simulation onto the dGG and φ4G order
parameters for the WT system (left, blue) and A21G system (right, green). The dGG
value was calculated as the distance between residues G33 (top) as well as between
G29 (bottom). Relative shade of points indicates a specific all-atom simulation.
6.3.2 A21G mutation alters GxxxG motif interactions
From the REMD simulations, representative frames were selected from both the WT and
A21G mutant systems to seed all-atom simulations. In order to simulate a variety of
structures, four frames were selected from both systems: left- and right-handed coiled-coil
structures at both small and large dGG values. In the WT system, the RH Gly-out frame
was taken from a simulation performed in a narrower, 30Å implicit GBSW membrane, in
which that region was more heavily sampled. These characteristic homodimer structures
were embedded in a POPC bilayer for 100 ns of simulation time.
As we have shown in previous studies [121], the WT C9915−55 homodimer system is best
characterized by interactions between residues G33 on each strand. Along the repeating
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Figure 6.3: Average ψCrick angles for each residue derived from all-atom simulations
of C9915−55 homodimers in POPC bilayer for all structures in the WT system (left)
and A21G system (right). Important residues are highlighted: glycine repeats (dark
green), G38 kink location (teal), V40 (yellow), A42 (orange), C-terminal threonines
(purple). Shades indicate respective peptides in the homodimer.
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GxxxG motif, the G33 residues are responsible for close interactions stabilizing the Gly-in
structure. This is seen in Fig. 6.2 (upper left) by the right-handed Gly-in cluster. Other
characteristic clusters for the WT system included: a Gly-side cluster (intermediate dGG
values, predominantly left-handed), and two separate left- and right-handed Gly-out clusters
(large dGG values). In the A21G system, however, projection onto the G33 dGG values
yielded no close interactions between the peptides. Since the A21G substitution extends
the existing GxxxG repeat to include an extra repeat of the motif N-terminally compared
to the WT, the dGG value was recalculated using the G29 residues instead of G33. In the
A21G system, both simulations that had yielded intermediate dG33−G33 values were found
to be stabilized primarily by G29 interactions (Fig. 6.2, bottom right), yielding two Gly-in
structures (one right-handed and one left-handed), as well as left- and right-handed Gly-out
structures.
To further examine specific interactions in each representative structure, the average
ψCrick angles at each residue were calculated over the last 50 ns of the trajectory (Fig. 6.3).
In the WT, the Gly-in structure is observed to be stabilized primarily by close interactions
between residues G33 and G37. In the A21G mutant, however, this interaction shifts
primarily to residues G29, especially in the left-handed structure. The Gly-out frames in
both systems show more similarity, with all structures showing closer contacts along the
G38xxxA42 interface reported in previous work [121].
6.3.3 A21G mutation reduces TM domain helicity
The helicity at each residue was calculated for simulations of each characteristic structure
and plotted in Fig. 6.4. In the WT system, for both the Gly-in and Gly-side substates,
at least one of the peptides maintains a helical juxtamembrane (JM) region, and both
peptides have very stable TM helices. In the Gly-in substates in the A21G mutant system,
however, the JM helicity is much less prominent. The predominant LH Gly-in structure
also shows a sharp drop in helicity in one of the peptides at the G37/G38 kink as well as
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Figure 6.4: Helicity values for each residue derived from all-atom simulations of
C9915−55 homodimers in POPC bilayer for all structures in the WT system (left)
and A21G system (right). Shades indicate respective peptides. Grey line indicates
helicity values calculated from Cα chemical shift NMR data [67].
in the C-terminal domain, both sites of γ-processing.
This C-terminal drop in helicity is seen in one peptide in each of the A21G systems,
beginning at residue V50, the common location of initial ǫ-cleavage by γ-secretase. This
drop in helicity has been previously reported in the WT C9915−55 system as a structural
modification of the TM domain facilitating γ-processing [127]. The stability of the TM helix
has been studied for its correlation to γ-cleavage, and it has been suggested that the loss
of helical structure near processing sites allows for cleavage to occur [36]. It has also been
posited that dimerization of the APP-C99 system increases the population of non-helical
conformations in the C-terminal portion of the TM region, promoting peptide processing
[29]. The prominence of this feature in the A21G system could make the mutant sequence
more available for cleavage, explaining the observed increase in Aβ production.
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Figure 6.5: Membrane insertion depths of each residue derived from all-atom simu-
lations of C9915−55 homodimers in POPC bilayer for all structures in the WT system
(left) and A21G system (right). Shades indicate depth of insertion derived from
respective peptides in the homodimer. Orange dashed lines indicate experimental
power saturation (EPR) measurements on WT C99 [90].
6.3.4 WT and A21G Gly-in structures display similar peptide position-
ing in lipid bilayer
The insertion depth of each residue was calculated by comparing the position along the
membrane normal to the center of the surrounding lipid head group atoms (Fig. 6.5). Posi-
tive values indicate residues above the head group, while negative values indicate reinsertion
into the lipid bilayer. In the WT sequence, the primary Gly-in structure displays reinsertion
of the JM LVFFA region into the lipid bilayer in agreement with experimentally reported
results [67, 92, 90]. In the other WT structures, however, one peptide shows moderate
reinsertion of the JM region while the other extends from the membrane surface.
In the A21G mutant sequences, the primary structure (LH Gly-in) was also characterized
by reinsertion of both peptides, while the RH Gly-in and Gly-out structures both contained
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one peptide with an extended JM region. This suggests that the A21G substitution affects
how the JM regions of the homodimers interact with each other and with the lipid bilayer,
resulting in the changes to the interface seen in Fig. 6.3.
The systems only displayed slight differences in the kink and tilt angles of the peptides
(Fig. 6.6). As was presented in previous studies on the WT C9915−55 structure [121],
the WT Gly-in structure is characterized by a right-handed structure featuring a tight
coiled-coil interface stabilized by close GxxxG contacts along residues G33 and G37. The
Gly-side structure commonly found in intermediate membrane widths has low kink and tilt
values for both peptides in the homodimer, and the Gly-out structures (associated with
narrow membrane environments and micelles [127]) are characterized by larger N-terminal
tilt values.
The A21G LH Gly-in structure, which was similar to the WT in terms of the JM
reinsertion (Fig. 6.5), is also characterized by an asymmetric homodimer, with one peptide
characterized by a straighter, extended TM helix and the second complementary strand
forming a prominent bend, facilitating close interpeptide interaction. This characteristic
asymmetry is observed in both the WT and A21G mutant peptides (Fig. 6.7), despite the
shift in the GxxxG interface. The sharp kink at residues G37/G38, causing a significant
drop in the helical nature of the TM region (Fig. 6.4), is accompanied by the loss of close
interpeptide contacts at residues G37 as well as G33, instead favoring contacts at residues
G29 at the N-terminal interfacial region of the peptides.
6.4 Discussion
6.4.1 A21G mutation shifts GxxxG interface in C9915−55 homodimers
The GxxxG repeat motifs in the TM sequence of APP have been of great interest as allowing
for close interpeptide contacts facilitating dimerization of the APP strand [54, 53, 29]. It
has been demonstrated experimentally as well as computationally that in the WT system
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Figure 6.7: Representative structures of WT (left) and A21G (right) peptides
derived from all-atom simulations of C9915−55 homodimers in POPC bilayer. Yellow
beads show the location of TM glycine residues. The lipid domain is marked as a
translucent surface, with head group regions highlighted in dark yellow.
these contacts occur primarily at residues G33 and G37 [91, 100, 121]. The A21G mutation,
however, extends the GxxxG repeat by one N-terminal motif, and it has been suggested
that this mutation could be responsible for a change in the dimer interface [91]. In this
study, the dominant form of the WT C9915−55 homodimer is a right-handed Gly-in structure
stabilized by close G33 and G37 contacts between peptides. In the A21G mutant system,
however, the dominant structure is a left-handed Gly-in structure where the main interface
has been shifted N-terminally to residues G29 on each peptide (Fig. 6.3).
It is also noted that while many differences are observed between the WT and A21G
Gly-in structures (both LH and RH), the Gly-out structures for both systems show more
similarities in terms of structural characteristics such as helicity, identity of residues forming
the homodimer interface, as well as kink and tilt angles. The structures characterizing the
C9915−55 A21G mutant peptide homodimer ensemble are stabilized primarily along the
G38xxxA42 interface described in previous studies [121, 91]. The similarities between these
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structures suggests that the effect of the A21G mutation is specific primarily to the GxxxG
interface motif.
6.4.2 A21G mutation alters TM peptide helicity
A21G substitution also led to a significant effect on the peptide helicity in C9915−55 ho-
modimers. Within the TM sequence, the A21G LH Gly-in structure is characterized by a
large drop in helicity at residues G37/G38 due to an increase in the kink angle in one of
the peptides (Figs. 6.4 and 6.6). In the JM region, the A21G mutation decreased helicity
overall, although both peptides show helical population at residues V24/G25, whereas in
the WT sequence, only one of the peptides contained helical content at these residues.
In both the WT and A21G systems it was observed that many structures were char-
acterized by the C-terminal end of one peptide being less helical; a feature found to be
more prominent in the A21G mutants. It has been suggested that homodimerization of
APP-C99 stabilizes helicity in the N-terminal TM region while destabilizing helicity in the
C-terminal domain near the ǫ-site, thereby facilitating γ-cleavage [29]. If this characteristic
is enhanced by A21G mutation, as suggested by our simulation results, it could play a role
in the increased γ-processing of the A21G mutants observed in previous studies [45, 126, 91]
6.4.3 Peptide positioning in lipid bilayer is only moderately affected by
A21G mutation
Despite significant changes to the secondary structure and interpeptide contacts of the
C9915−55 homodimers, both the WT and A21G systems were found to have similar interac-
tions with the lipid bilayer, as demonstrated by similar patterns of residue insertion depth
as well as peptide kink and tilt angles within the POPC bilayer.
The predominant structure characterizing the homodimer ensemble of both sequences
was characterized by reinsertion of the L17VFF20 region into the lipid bilayer (Fig. 6.5);
a structural feature which our previous work has suggested might have a critical effect
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on normal γ-processing[128]. For homodimers formed from the C9915−55 WT or A21G
sequences, the structures were found to be asymmetric, with one peptide forming a largely
straight, extended TM helix and the complementary strand forming a prominent bend with
much larger kink and tilt angles (Fig. 6.6). This structural feature was greatly enhanced in
the A21G mutant homodimer, where the kink angle was up to 30 degrees larger than was
found in the WT homodimer.
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Chapter 7
Conclusion
7.1 Summary
The work presented here has explored fundamental aspects related to the structure and
dynamics of C99 peptide monomer and homodimer, including dependence on sequence and
membrane environment, that are critical to our understanding of the genesis of Aβ-peptide
from the processing of APP-C99 by γ-secretase. By investigating a collection of systems
consisting of fragments of C99 of varying length and sequence as well as in a variety of lipid
environments, we addressed the following critical questions: What role does the sequence of
APP play in the γ-processing pathway? How do both engineered and familial mutants affect
the structure and interactions of C99 peptides, and how might those changes alter their
subsequent processing? How sensitive are the structure and positioning of C99 monomers
and dimers to their surrounding environment? How do changes in the environment alter
the structure and especially the homodimer ensemble of APP-C99? Our main findings are
presented here.
7.2 Key Findings
K28 mutations. The results presented in this study inform the following conclusions about
C991−55 in a bilayer environment: (1) The WT C991−55 peptide is characterized by two
dominant structural forms marked by a helical and β-structured JM domain, respectively.
The existence of this ensemble suggests a flexible JM region, and provides support for
experimental results that have shown the existence of both helical and β-structured forms.
(2) The CHC of C991−55 independently adopts a helical structure or reinserts into the
bilayer. This result extends the understanding developed in previous studies that posited
76
the existence of a helical CHC region and its reinsertion in the lipid bilayer. We find that the
system exists as two distinct states (helical and non-helical), which may be dependent on
both peptide sequence and lipid composition. (3) Mutations at K28 have a pronounced effect
on the structural ensemble and positioning of the C991−55 peptide. These effects include
destabilization of the salt-bridge formed between K28 and residues E22/D23, extension of
the TM helix, as well as increased kink and tilt angles of the peptides within the bilayer.
These results provide insight into structural changes in C99 that may underly changes in
γ-processing of mutant peptides observed in previous works.
C9915−55 homodimers. We find that the C9915−55 system is best characterized by
an ensemble of structural forms. (1) The C99 peptide contains three main helical regions:
the TM region consisting of N-terminal and C-terminal helices, as well as a less-stable JM
helix region. (2) The C9915−55 ensemble also includes a variety of homodimer structures,
characterized by different, distinct peptide interfacial regions. These features are best de-
scribed by the relative location and orientation of the key residues G33 and G37 - part
of the GxxxG repeat motif - as being Gly-in, Gly-side, or Gly-out, and include both left-
and right-handed coiled-coil interactions between the peptides. (3) Clustering simulations
according to local membrane character suggests a role for “environmental selection” of these
different substates.
C9923−55 homodimers in varying lipid environment. In agreement with our stud-
ies on C9915−55 homodimers, we find that homodimers of the TM sequence of APP are
characterized by an ensemble of forms which are highly sensitive to local membrane en-
vironment. (1) By simulating C9923−55 homodimers in a variety of implicit and explicit
lipid environments, we demonstrate a distinct shift in dimer interface as membrane width
is varied. (2) While wider bilayer systems are characterized by predominantly right-handed
Gly-in structures, narrowing the bilayer environment is found to shift sampling more heav-
ily towards Gly-side and Gly-out structures. (3) While previous experimental studies have
observed that varying lipid composition may [36] or may not [30] impact TM domain helic-
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ity, the results of this study suggest that the TM domain helicity is not a sensitive function
of lipid composition for the lipid bilayers studied. These findings can help explain the dif-
ferences in experimentally-reported structures of APP-C99 dimers, which have been carried
out in a variety of lipid and micelle environments.
FAD Flemish A21G mutation. The juxtamembrane region of APP-C99 has often
been studied for its central importance as a precursor protein processed by γ-secretase
to produce Aβ-peptide of central importance to AD [93]. In order to understand the
relationship of sequence in the production of Aβ, there has been substantial interest in
examining the impact of both FAD [44, 45, 126, 91] and engineered [46, 47, 48, 49, 50, 128]
mutations on the processing of APP-C99 by γ-secretase. There has also been interest in
the importance of TM helix stability in the availability and processing of APP-C99 [36, 29].
While many characterized FADmutants have been shown to alter the ratio of Aβ42/Aβ40
[85, 87], the Flemish A21G mutation is thought to operate via a separate mechanism, lead-
ing to cerebral haemorrhage and early death [44]. This study examined the effect of A21G
mutation on the structure and dimerization of APP-C9915−55 peptides in order to provide
insight into the role of FAD mutation on the structure and processing of APP-C99.
The results of our work lead to the following conclusions about the impact of the Flemish
A21G FAD mutation: (1) The A21G substitution, which extends the well-known GxxxG
repeat motif, extends the dimer interface from interpeptide contact at residues G33 and
G37 to include residues G29. (2) The TM helicity of A21G mutant peptides is significantly
lower both at the G37/G38 kink as well as at the C-terminal end of the homodimer, both
locations of processing by γ-secretase. (3) Peptide positioning (characterized by residue
insertion profiles as well as peptide kink/tilt angles) is only moderately affected by A21G
mutation. Although it remains possible that the pathological effect of A21G substitution is
caused by other effects - including direct interactions between the JM region and γ-secretase,
which remains outside the scope of this work - this study provides valuable insight into the
effect of this mutation on the structure and specific chemical interactions of the system.
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7.3 Future Work
The studies presented here provide a foundation for future computational and experimental
studies exploring the role of sequence and membrane in the structure and dynamics of C99
in lipid bilayers. While we have gained insight into the structure and dynamics of C99
monomer and homodimer, putative substrates for cleavage by γ-secretase, many questions
remain surrounding specific details related to the interaction of C99 with γ-secretase, γ-
cleavage and Aβ production. In particular, recent progress in the elucidation of a structural
homologue to the presenilin active site domain of γ-secretase [129] has opened the door for
computational studies investigating detailed intermolecular interactions between APP and
the γ-secretase active site. Some early studies probing the interactions of C99 monomer
with the homologue of presinilin have already been started in our lab, and we hope to see
more work continue in this area.
A significant number of FAD mutants of C99, known to impact the cleavage of C99
by γ-secretase and the resulting Aβ product distribution, have been identified. It would
be fruitful to apply the computational models developed and, to a degree, validated in
the studies presented here to an expanded number of FAD mutant sequences, including
representatives of the London and Florida FAD mutant peptides. Those additional studies
promise to provide molecular-level insights into the changes in the structure of C99 monomer
and homodimer induced by FAD mutations, which can help answer vital questions into the
pathological effects of these single-site substitutions.
Finally, we hope that results presented here will inspire experimental work to provide
a critical test of our findings related to the impact of varying sequence and membrane
environment on C99 structure and dynamics, and to extend those results to provide insight
into the relationship between C99 structure and activity, its cleavage by γ-secretase in the
production of Aβ.
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